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1 General Introduction 
 
Vertebrates are constantly exposed to a variety of potentially pathogenic 
microorganisms, like bacteria, viruses or fungi, against which they have to defend 
themselves. In millions of years an effective and protective mechanism, the immune 
system, evolved. This potent defense machinery consists of two separated but 
interacting parts. One, termed innate immunity, is more unspecific relying on a 
number of barriers that are effective against a wide variety of pathogens. The other is 
the adaptive immunity being specific for particular microorganisms or molecules. Key 
players of the adaptive immunity are the B lymphocytes (B cells) and T lymphocytes 
(T cells). Together, they are able to respond to virtually any kind of pathogen or 
molecule based on the great diversity of their antigen specific receptors, the B cell 
receptor (BCR) of B cells and the T cell receptor (TCR) of T cells.  
 
1.1 V(D)J recombination  
 
1.1.1 Organization of the BCR complex and its genomic locus 
 
The BCR is a protein complex composed of two identical heavy and light chains. 
Each of the two light chains is covalently linked by a disulfide bond to one of the two 
heavy chains, which in turn are also covalently linked by disulfide bonds (see figure 
1.1 A). The amino-terminal region of a light and heavy chain vary greatly among 
antibodies of different specificity. These domains of highly variable sequence are 
called V regions and constitute the antigen-binding site. Variability in the V regions is 
not uniformly distributed, but is very pronounced in three segments, termed 
complementarity-determining regions (CDRs), forming most of the antigen-binding 
site. The regions with relatively constant sequence, beyond the variable regions, are 
called C regions. Heavy and light chain comprise several protein domains, forming 
antiparallel β pleated sheets which are folded into globular domains, hence they are 
also called immunoglobulins (Igs). Immunoglobulins can be expressed either 
membrane bound, as BCR, or secreted as soluble antibody, depending on alternative 
splicing of the primary mRNA in- or excluding the trans-membrane region encoding 
exons (Early et al., 1980; Rogers et al., 1980). BCR cell surface deposition also 
requires the expression of two accessory membrane proteins called Ig-α (mb-1) and 
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Ig-β (B29) forming a heterodimer (Hombach et al., 1990). Both proteins contain two 
immunoreceptor tyrosine based activation motifs (ITAMs) and are responsible for the 
signal transduction upon BCR engagement. 
Immunoglobulin genes are located in three different genomic loci (see figure 1.1 B). 
The Ig heavy (IgH) chain locus is found on chromosome 12 in the mouse. The locus 
spans over 2 Mb and comprises regions coding for over 100 variable (V1-500), 13 
diversity (D1-12), 4 joining (J1-4) and 8 constant (Cµ, δ, γ3, γ1, γ2b, γ2a, ε, α) gene 
segments. The VH gene segments are grouped into 15 families based on their coding 
sequence homology. Chromosome 6 harbours the κ light chain locus, comprising 
nearly 100 functional variable, 4 functional joining and 1 constant gene segment. 
The λ light chain locus is located on chromosome 16 consisting only of 3 variable, 3 
joining and 3 constant gene segments. In contrast to the IgH locus, the Ig light (IgL) 
chain gene loci include no diversity gene segments. 
 
1.1.2 Organization of the TCR complex and its genomic locus 
 
Depending on the expression of their T cell receptor genes, T cells are subgrouped 
into αβ and γδ T cells. αβ T cells express disulfide linked heterodimers of a TCR α 
chain together with a TCR β chain (see figure 1.1 A). Within a given species the C-
terminal regions of the TCR α, β, γ or δ chains are non-variable, while the highly 
variable N-terminal regions, like in the Ig molecules, form the antigen binding site. 
Expression and signaling depends, like for the BCR, on the presence of accesory 
proteins, in this case the CD3 complex (Samelson et al., 1985). This complex consists 
of five invariant proteins, forming three different dimers: a heterodimer of γ and ε 
chains, a heterodimer of δ and ε chains and a homodimer of two ζ chains or a 
heterodimer of ζ and η chains. All chains are characterized by the presence of at least 
one ITAM, essential for signal transduction. Unlike Igs, the TCR is only found as a 
membrane bound complex. Classical αβ T cells do additionally express either the 
CD4 or CD8 coreceptor and are accordingly grouped into CD4+ or CD8+ T cells. 
Depending on the expression of the coreceptor, they are restricted to recognize 
presented peptide antigens either in the context of major histocompatibility complex 
class I (MHC clI) (CD8+ T cells) or class II (MHC cl II) (CD4+ T cells). Non-classical 
αβ T cells and γδ T cells  can  also  recognize  non-peptide  and  unprocessed peptide 
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Figure 1.1: Schematic representation of the BCR and TCR (A) and the Ig genomic locus (B) and 
TCR genomic locus (C) in the mouse. Adapted from (Kuby, 2001). 
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antigens, presented either by classical or non-classical antigen presenting molecules. 
The genes encoding the TCR chains are similarly organized like the Ig genes (see 
figure 1.1 C). The β chain locus in the mouse, located on chromosome 6, and the δ 
chain locus, found on chromosome 14, comprise several V (β: n=25, δ: n=10), D (β: 
n=2, δ: n=2), and J (β: n=12, δ: n=2), gene segments. The α (chromosome 14) and γ 
(chromosome 13) chain loci only contain V (α: n=100, γ: n=7), and J (α: n=50, γ: 
n=3) gene segments. Interestingly, the α chain locus is located on the same 
chromosome as the δ chain locus. In fact, the latter is embedded in the α chain locus. 
As a consequence, upon rearrangement of the α chain locus the δ chain locus is 
deleted, commiting a T cell irreversibly to the αβ lineage. 
 
1.1.3 V(D)J recombination 
 
Diversity of the antigen receptors of B and T cells is generated by a somatic gene 
rearrangement process. During this process single variable (V), sometimes diversity 
(D) and joining (J) gene segments are recombined together by a mechanism termed 
accordingly V(D)J recombination (Tonegawa, 1983). Rearrangement is a stepwise 
process, first rearranging a D to a J gene segment and subsequently a V to the 
prearranged DJ, in case of the IgH or the TCR β locus. The V and J elements of the 
IgL and TCR α/γ loci are directly joined. Gene segments are flanked by so called 
recombination signal sequences (RSS), which consist of a conserved palindromic 
heptamer and an AT-rich nonamer separated by a nonconserved spacer of either 12 or 
23 base pairs. Recombination takes place only between two segments which are 
neighboured by RSS with different spacer length, referred to as the 12/23 rule (Schatz 
et al., 1992). Rearrangement is initiated by the binding of the recombination activating 
gene (RAG) proteins 1 and 2 to a pair of RSS (McBlane et al., 1995; van Gent et al., 
1995). Eventually, a precleavage complex is formed where the RSS, together with the 
adjacent coding regions, are brought into close proximity. A single strand nick is 
introduced by the RAG proteins right at the border between the coding sequence and 
the RSS. The liberated 3´-OH group of the coding gene segment then attacks, 
catalyzed by the RAG proteins, in a direct transesterification reaction the 
phosphodiester bond on the opposite DNA strand. Thereby a hairpinned coding end  
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and a blunt ended signal end are created, the latter still retaining the RSSs (van Gent 
et al., 1996). 
The DNA ends are held in a stable postcleavage synaptic complex (Hiom and Gellert, 
1997) to which then general DNA repair factors of the non homologous end joining 
(NHEJ) DNA repair pathway are recruited to perform processing and ligation of the 
DNA ends. Ku86 and Ku70 form a DNA binding heterodimer (Ku) which recruits 
another NHEJ factor, the DNA-PK-catalytic subunit (DNA-PK-cs), forming together 
the DNA-PK holoenzyme (Gottlieb and Jackson, 1993). This complex recruits and 
activates XRCC4 which in turn forms an DNA end-ligation complex together with 
DNA ligase IV, which is responsible for joining of the DNA ends (Grawunder et al., 
1997; Li et al., 1995). Artemis, an additional NHEJ factor, is also recruited into the 
complex and activated (Moshous et al., 2001). Deficiency in any of the six NHEJ 
factors results in severe combined immunodeficiency (SCID), lacking B and T cells, 
due to the inability to process and join RAG cleaved coding ends and form complete 
antigen receptor genes. Ligation of signal ends, in contrast, still occurs in the absence 
of DNA-PK-cs or Artemis, reflecting the differential needs for further processing of 
signal and respectively coding ends. 
 
Fig. 1.2. Schematic representation of V(D)J recombination. CE = coding end, P = palindromic 
nucleotide, N = nontemplated nucleotide, CJ = coding joint, SJ = signal joint. Adapted from 
(Grawunder and Harfst, 2001). 
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Signal ends can be ligated without any further processing, generating a signal joint 
retaining both RSSs. In vivo they are formed with over 95% fidelity and can be 
detected as extrachromosomal excision circles in case of a deletional recombination 
event. In contrast, hairpinned coding ends have to be opened before the XRCC4/DNA 
ligase IV complex can form a coding joint. Hairpin nicking can occur at the tip or off-
center, the latter generating either a 3´ or 5´ overhang. 3´ extensions have, normally, 
to be resected before ligation can take place, unless both coding ends have compatible 
regions, leading to the deletion of a few nucleotides in the joining. A 5´ overhang, in 
contrast, can directly be filled in, generating thereby short palindromic regions, 
termed P nucleotides. The terminal deoxynucleotidyl transferase (TdT) a lymphocyte 
specific protein, not belonging to the NHEJ repair pathway, is also involved in the 
processing of the coding ends, adding occasionally nontemplated nucleotides (N 
nucleotides) to the coding ends (Gilfillan et al., 1993). Combinatorial association of 
V, D and J gene segments, coupled with imprecise processing of the coding ends and 
N-nucleotide addition, produce together an enourmous repertoire of primary B cell 
and T cell receptors. 
 
1.1.4 Regulation of V(D)J recombination 
 
The V(D)J recombination machinery is responsible for assembling gene segments of 
the immunoglobulin as well as the TCR locus. Thus, V(D)J recombination has to be 
tightly regulated in a stage and tissue specific way. To account for the different levels 
of regulation, an accessibility model has been proposed, whereby germline RSS sites, 
which are inaccesssible for the recombination machinery due to chromatin structure or 
modification, must be actively „opened“ before recombination takes place.  
Transcriptional enhancers embedded within antigen receptor loci have been 
extensively documented to play a role in tissue- and stage-specific assembly of 
endogenous antigen receptor gene segments (Krangel, 2003). Correspondingly, 
deletion of enhancer elements from endogenous mouse Ig and TCR loci blocks or 
significantly impairs V(D)J recombination of the corresponding loci, concomitant 
with impaired germline transcription (Bouvier et al., 1996; Mathieu et al., 2000). 
Numerous studies over the years have further shown that transcription is strongly 
correlated with, but not necessarily sufficient for rearrangement of adjacent antigen 
receptor gene segments (Senoo et al., 2001; Sikes et al., 1999). It is also not clear, if 
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germline transcription might not constitute a by-product arising from an accessible 
locus.  
Generally, the role of enhancers is to open the locus to facilitate assembly of the basal 
transcription machinery on promoters via mechansims that involve general chromatin 
opening assocciated with histone acetylation, CpG demethylation, recruitment of 
transcriptional coactivators and repositioning of promoter bound nucleosomes. These 
processes are likely interdependent as, for example, transcriptional coactivators often 
contain histone acetylase activities. Many of these events also have been implicated in 
regulation of V(D)J recombination. For example, CpG demethylation was recognized 
as an attribute of V(D)J accessible loci (Inlay and Xu, 2003; Mostoslavsky et al., 
1998), although by itself ist is not sufficient and/or required for VDJ recombination 
(Cherry et al., 2000; Gauss et al., 1998). Additionally, it was shown that CpG 
methylation can inhibit binding of RAG1/2 to the RSS and that direct methylation of 
the RSS hampers V(D)J cleavage. Enhancers, additionally, direct stage-specific 
acetylation of histones in chromatin of the antigen receptor genes in a pattern that 
strongly correlates with V(D)J accessiblity (Mathieu et al., 2000; McMurry and 
Krangel, 2000), but histone acetylation may also not be sufficient to generate full 
accessibility (Senoo et al., 2001). Histone methylation has also been shown to 
negatively regulate V(D)J recombination (Osipovich et al., 2004). Nucelosomal RSS 
packaging in vitro inhibits V(D)J recombination and in some instances can be 
alleviated via histone acetylation and/or the actions of nucleosome-remodeling 
complexes (Golding et al., 1999; Kwon et al., 1998; Kwon et al., 2000). However it 
remains uncertain whether nucleosomes inhibit RAG access in vivo, since full-length 
RAG2 itself has been hypothesized to posess chromatin remodeling activity (Kirch et 
al., 1998; Liang et al., 2002). Early replication (Mostoslavsky et al., 2001) and central 
subnuclear positioning (Kosak et al., 2002) are also potentially important in regulating 
VDJ recombinational accessibility. As with transcription, it is not clear whether any 
or all of these correlates act/s as causes or are only effects of an open locus. 
Mechanisms directing and stabilizing synapsis of V and (D)J RSS located over large 
(1-2 Mb) chromosomal distances also remain to be determined. Probably, an active 
coupling of RAG accessible V and D RSS takes place, as random collision between 
RAG bound RSS seems inefficient. In this respect, recent experimental data are 
interesting implicating the transcription factor Pax5 in the contraction of the IgH 
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chain locus, facilitating thereby rearrangement of distal VH-DJH gene segments (Fuxa 
et al., 2004). By what mechanism this contraction is achieved remains to be explored. 
Finally, controled and coordinate expression of the RAG genes is another mechanism 
to regulate V(D)J recombination. Several genetic elements are involved in the 
lymphocyte and stage specific expression of RAG1/2 (Hsu et al., 2003; Monroe et al., 
1999; Yu et al., 1999). In both B and T cells, levels of RAG2 are controled by RAG2 
protein degradation during transition from G1 to S phase, limiting RAG2 presence to 
the G0/G1 phase of the cell cycle (Lin and Desiderio, 1995). A recent report described 
an E3 ubiquitin ligase activity for RAG1, raising the possibility that this activity may 
be involved in degrading proteins, possibly also the RAG proteins themselves (Mizuta 
et al., 2002), to regulate V(D)J recombination (Yurchenko et al., 2003). This tight 
control of RAG protein expression seems to be important especially in the context of 
generation of DNA double strand breaks (DSB), which are always a potential danger 
for the integrity of the genome.   
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1.2 B cell development 
 
1.2.1 B cell development in the bone marrow 
 
B cell development takes place in the bone marrow, a primary lymphoid organ in 
mammals. B cells derive from hematopoietic stem cells (HSC). Analysis of the 
developmental potential of different stem cell and progenitor populations shows that 
HSC can develop into different directions entering either the megakaryocyte-platelet 
pathway or developing into the myeloid/lymphoid lineage (Katsura, 2002). The 
question if development then proceeds through a „pure“ lymphoid progenitor, a so 
called common lymphoid progenitor (CLP), or rather through separated B and T 
progenitors retaining myeloid potential is still a matter of debate. 
Several nomenclatures are used in different laboratories characterizing the stages of B 
cell development according to their cell surface phenotype and the rearrangement 
status of their immunoglobulin loci. Table 1 cross-references the different 
nomenclatures.  In this work, the nomenclature according to Rolink and Melchers will 
be employed.  
The earliest types of characterized B cell progenitors are the pre/proB cells (see figure 
1.3 A). Pre/proB cells are positive for the pan B cell marker B220 and additionally 
they express the interleukin 7 receptor α-chain (IL7-R, CD127) as well as the receptor 
for stem cell factor CD117 (c-kit). The following stage, proB cells, are phenotypically 
very similar but have gained CD19 expression. CD19 forms part of the B cell receptor 
(BCR) complex. The CD19 gene is a direct target of the transcription factor PAX5, 
thought to be responsible for B cell lineage commitment (Nutt et al., 1999). ProB cells 
start rearranging their IgH chain loci and eventually become preB-I cells. PreB-I cells 
have DJ rearrangements on both IgH alleles. Their surface phenotype resembles that 
of proB cells, with CD19, c-kit and IL7-R expression.  
 
 
Table 1: Nomenclatures for B-lineage cells used by different laboratories. 
 
 
Rolink and            Pro-B         PreB-I                                Large preB-II        Small preB-II     Immature B      Mature B 
  Melchers 
Osmond             Early pro-B         Intermediate                       Late preB/             Small pre-B       Immature B      Mature  B 
                            pro-B                 large preB-II    
Nishikawa             B-Pro I PA6 only    B-Pro I PA6-IL7                CFU-IL-7 only 
Hardy -    A                      B           C          C´                                         D                        Immature B      Mature  B 
                                       Pre/pro-B    Pro-B    Pro-B 
 
General Introduction 
10 
PreB–I cells start to rearrange the prearranged DJH segments to a V heavy (VH) chain 
gene segment, thereby producing a µH chain. The synthesized µH chain is then tested 
for pairing with the surrogate light chain (SL), consisting of a VpreB and a λ5 protein, 
which associated resemble a λ light chain. The complex of a SL together with a µH 
can be expressed on the cell surface, as a so called preB cell receptor (preBCR). First, 
only one allele is rearranged and in the case of a productive rearrangement, the cell 
proceeds to the following developmental stage. Only if no preBCR is expressed, will 
the second allele be rearranged. This sequential type of rearrangement ensures that a 
B cell will express only one µH on the cell surface, thereby avoiding cells with two 
different specificities, a mechanism called allelic exclusion (Nussenzweig et al., 
1987).  
After succesful rearrangement RAG-1/2 and TdT are downregulated and the cells 
become cycling large preB-II cells (Grawunder et al., 1995). These cells lose c-kit 
expression, gain CD25 expression and are positive for cytoplasmic µH. Initially they 
still show CD43 and also preBCR expression, which they eventually lose. Upon 
preBCR expression large preB-II cells undergo 2-5 rounds of division and become 
afterwards resting small preB-II cells (Rolink et al., 2000). The recombination 
machinery, except TdT, is upregulated again and the cells start to rearrange their IgL 
chain loci. Rearrangement is initiated more often at the κL chain locus then at the λL 
chain locus, resulting in a ratio of 10:1 κL chain to λL chain expressing B cells (ten 
Boekel et al., 1995). Upon a succesful rearrangement the cells become surface IgM 
(sIgM) positive immature B cells, expressing intermediate levels of B220 and low to 
high levels of sIgM. Immature B cells expressing a BCR with auto-reactivity are 
negatively selected in the bone marrow, exposure to antigen results in downregulation 
of sIgM and B220 expression (Hartley et al., 1993). Since these cells still express 
RAG-1 and RAG-2 they can undergo secondary L chain rearrangements, a rescue 
mechanism termed receptor editing (Gay et al., 1993). Thereby they possibly can still 
escape negative selection. Also cells with L chains not at all or only insufficiently 
pairing with the µH chain can undergo secondary L chain rearrangement, thus 
improving the quality of their BCR. Only sIgMhigh immature B cells leave the bone 
marrow to enter the spleen (Rolink et al., 2004). Nonetheless, of the ca. 2x107 B cells 
that develop daily in the bone marrow, only about 10-20% will enter the spleen (ten 
Boekel et al., 1998).  
   General Introduction 
11 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3: Schematic representation of B cell development in the bone marrow and spleen (A) 
and of the structure of the spleen (B/C). A) BM = bone marrow, T = transitional type B cell, 
FOB= follicular B cell, MZB = marginal zone B cell. B) PALS = periarteriolar lymphoid sheath. 
Adapted from (Paul, 1998). C) Arrows indicate flow of blood. DC = dendritic cell, MZ = marginal 
zone, FOB = follicular B cell, MZB = marginal zone B cell. Adapted from (Tanigaki et al., 2003). 
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1.2.2 B cell development in the spleen 
 
Immature B cells transit via the blood to the spleen (see figure 1.3 B/C). They first 
enter via the terminal branches of the central arterioles the marginal sinuses, to reach 
the outer zone of the periarteriolar lymphoid sheath (PALS) (Liu, 1997). In the spleen, 
immature B cells pass through further developmental stages, until about 50% enters 
the pool of mature long-lived B cells (Rolink et al., 2004). Three sequential, short 
lived transitional B cell stages have been distinguished, transitional type 1 cells (T1), 
T2 and T3 cells (see figure 1.3 A). All cells of the transitional compartment are 
characterized by the expression of the C1q-like receptor C1qRp (CD93) recognized 
by the 493 antibody (as well as by the AA4.1 antibody). T1 cells are 
IgMhigh/IgDlow/CD19+/B220+ but still CD21-/CD23-. They appear to be localized at the 
outer limits of the PALS whereas T2 migrate to the B cell follicles (Liu, 1997; Loder 
et al., 1999). T2 transitional cells become CD21 and CD23 positive and gain a higher 
level of IgD expression. T3 show the same cell surface phenotype as T2 cells, except 
that they express lower levels of sIgM. During development through the transitional 
stages, the cells respond differently to BCR engagement. Whereas T1 cells, like 
immature B cells, still undergo apoptosis upon stimulation of the BCR, later stages 
seem to be resistant to apoptosis and acquire the ability to proliferate (Chung et al., 
2003). There is some disagreement in the literature if this change in responsiveness is 
already acquired at the T2 stage or rather in the mature stages.  
Mature B cell stages are all 493-. Most prominent in the spleen are the follicular B 
cells (FOB). They are characterized by CD23/CD21/IgM/IgD/CD19/B220 expression, 
located inside the follicles (see figure 1.3 B/C) and participate mainly in the thymus 
dependent (TD) immune responses including the germinal center formation. The other 
main mature B cell subset of the spleen, though much less abundant, are the marginal 
zone B cells (MZB). The cells are CD21+/IgMhigh/CD19+/B220+ but in contrast to FOB 
CD23-/low/IgD-/low. Topographically, they are located at the outer rim of the follicles, 
neighbouring the marginal sinus in close interaction with the marginal zone 
macrophages and dendritic cells (see figure 1.3 B/C). The origin of MZB cells is still 
a matter of debate. Some authors suggest that they are directly derived from T2 cells 
(Saito et al., 2003) whereas other experimental data indicate that MZBs originate from 
FOB or even memory B cells (Vinuesa et al., 2003). MZB are thought to constitute a 
first line of defense against blood-borne antigens based on their optimal topographical 
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position right beside the marginal sinuses, where the post-arterial blood flow 
circulates. They mainly participate in thymus independent (TI) responses. MZB easily 
generate IgM secreting plasma cells and can become potent antigen presenting cells 
(Martin et al., 2001; Oliver et al., 1997; Oliver et al., 1999). The strategical 
localization together with their functional properties make them predestined to react to 
blood borne pathogens, thereby helping to bridge the time interval between the 
immediate innate immune response and the delayed TD adaptive immune response.  
Another mature B cell population, B1 B cells, participates in this early response. B1 B 
cells are mostly involved in TI responses and are the major source of natural IgM 
(innate, IgM secreted without apparent antigenic presence) in the serum. Natural 
antibodies are important in the early immune response since they can have a 
protective role, delaying pathogenicity of infecting agents until antigen-induced high 
affinity Igs of all isotypes are produced (Baumgarth et al., 2000). B1 B cells are not 
very numerous in the spleen but constitute the main B cell population in the peritoneal 
and pleural cavities. They develop prior to weaning and further persist as a self-
replenishing population. 
 
1.2.3 Factors influencing formation of mature B cell populations 
 
The mechanisms influencing selection of B cells into one compartment or the other 
are not yet fully resolved. Different naturally occuring and experimentally induced 
mutations affecting B cell development have helped our understanding of factors that 
are involved B cell lineage decision. 
Enrichment of certain antigen specifities in the B1 and MZB compartment suggest 
that the selection into one population or the other is influenced by the presence of 
antigen, either self or foreign. Additionally, transgenic mice expressing certain self-
reactive heavy chains show an enrichment of cells in the MZB compartment (Martin 
and Kearney, 2000). Also mutations affecting BCR signaling influence the lineage 
decision. CD19 and CD21 function together as coreceptor of the BCR to lower the 
threshold of BCR signaling, but CD19 can also have CD21 independent negative 
regulatory effects on BCR signaling. CD19-/- mice lack B1 cells as well as MZB 
(Martin and Kearney, 2000; Rickert et al., 1995) whereas CD21 deficient mice show 
an enlarged MZB compartment (Cariappa et al., 2001). Deficiency in CD22, a 
negative regulator of BCR signaling, leads to reduced MZB cell numbers; in contrast 
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B1 B cells are present in normal numbers (Samardzic et al., 2002). Several other 
mutations affecting BCR signaling, including intracellular components of the 
signaling machinery, have been analyzed in respect of their effect on B lineage 
decision. Nonetheless, a conclusive picture of how BCR signaling and its strength are 
involved could not yet be drawn.  
Mutations and manipulations of integrins and factors involved in migration and 
adhesion also affect B cell subpopulations and their localization differently. 
Combined inhibition of the integrins LFA-1 and α4β1 for example causes a rapid and 
selective release of B cells from the MZ (Lu and Cyster, 2002). Deficiency in Pyk2, a 
tyrosine kinase essential for migration and adhesion in response to chemokine and 
integrin signals, leads to a defect in MZB cells (Guinamard et al., 2000). 
Also Notch signaling is involved in the lineage decision. Initially, it was found that 
mice deficient for RBP-J, a transcription factor downstream of Notch, lack MZB cells 
(Tanigaki et al., 2002). Later on, it could be shown that Notch2 is involved in MZB 
generation. Mice lacking Notch2 have no MZB cells (Tanigaki et al., 2002). Already 
Notch2 haploinsufficiency leads to a reduction of MZB cells as well as of B1 B cells 
(Witt et al., 2003). The corresponding Notch ligand was found to be Delta-like 1 
(Hozumi et al., 2004). 
Mutations affecting the rate of B cell generation also influence the B cell linage 
decision. Mice deficient in the B cell survival and differentiation factor BAFF or 
BAFF receptor lack FOB and MZB cells, but have a normal B1 B cell compartment. 
Conversely, mice transgenic for BAFF show an enlarged T2 compartment and 
increased numbers of mature B cells, especially MZB (Rolink and Melchers, 2002). In 
contrast, increased bone marrow B cell generation in IL-7 over-expressing mice leads 
to a massive expansion of FOB cells, but MZB cell numbers slightly decrease 
(Ceredig et al., 2003). IL-7 deficient mice have a block in early B cell development. 
Nonetheless, the mice have a normal B1 B cell compartment and most of the 
generated peripheral B2 B cells resemble MZB cells (Carvalho et al., 2001). Also in 
genetically manipulated mice in which B cells are only formed in the perinatal period, 
B1 B cells are present and most of the persisting B2 B cells belong to the MZB 
compartment (Hao and Rajewsky, 2001). Thus, it seems that in a B lymphopenic 
situation there is a tendency of B cells to develop into the more „innate“ 
compartments.  
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The question of how lineage decisions are made in B cells and what factors influence 
them, is therefore not yet solved. Different mechanisms have been implicated like for 
e.g. strength of the BCR signaling or antigenic selection. But, it still remains to be 
seen what holds true and if not a combination of several mechanisms is involved in 
the decision of a B cell which way to go. 
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1.3 Thesis objectives 
 
V(D)J recombination is the mechanism generating the enormous diversity of antigen 
receptors of B and T cells. Many factors directly involved in the mechanism or in the 
regulation of it have been discovered like for example RAG1/2, proteins essential for 
the rearrangement to take place. But still, certain aspects of the mechanism have not 
yet been elucidated completely, and in fact, it has not been possible until now to 
reconstitute V(D)J recombination biochemically with purified proteins.  
 
One step, which at the beginning of thesis had not been resolved unequivocally, is the 
opening of the hairpinned coding ends. Several proteins have been implicated in this 
process, including the RAG proteins themselves (Besmer et al., 1998; Shockett and 
Schatz, 1999), which were shown to open coding ends in vitro.  
The Nbs1/Mre11/Rad50 complex has also been hypothesized to be responsible for the 
nicking of the coding ends. This DNA repair complex was shown to open hairpinned 
coding ends in vitro (Paull and Gellert, 1999). Additionally, its homologues in yeast 
participate, amongst others, in the NHEJ DNA repair mechanism. Until now all 
factors of the NHEJ DNA repair pathway also have been shown to participate in 
V(D)J recombination, therefor it would be conceivable that the Nbs1/Mre11/Rad50 
complex is also involved in V(D)J recombination and that, in fact, it constitutes the 
hairpin opening activity. A detailed analysis of V(D)J recombination in cells of 
patients with a mutation in the Nbs1 gene, suffering from the genetic instability 
disorder Nijmegen breakage syndrome (Varon et al., 1998), should help to test this 
hypothesis. 
 
Another factor, identified based on its RSS binding ability (Wu et al., 1993), the 
kappa B and RSS recognition component (KRC) has also been hypothesized to be a 
yet unidentified protein participating in the regulation or directly in the mechanism of 
V(D)J recombination. The expression pattern of KRC, being mainly lymphoid apart 
from neuronal (Wu et al., 1996), together with the affinity to the RSS, additionally 
shown to be regulated (Wu et al., 2001), would correspond to it. Targeting of the KRC 
locus in the mouse and subsequential analysis of the effects of KRC deficiency on 
lymphoid development, especially on V(D)J recombination, should help to clarify the 
role of KRC. 
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The first completely assembled protein product of V(D)J recombination during B cell 
development is the µH chain. In preB-II cells the µH chain is „quality-tested“ by co–
expression with the SL chain for pairing and surface expression. Successfull 
deposition of the preBCR complex on the cell surface allows the cells to expand and 
develop further. Deficiency in one of the components of the SL, the λ5 protein, leads 
to a block in early B cell development (Kitamura et al., 1992). However, the block is 
not complete allowing the generation of some mature B cells. Since in other 
experimental systems it has been shown, that the rate of B cell generation influences 
the shaping of mature B cell populations, the question is how λ5 deficiency and the 
concomitant reduction in B cell generation affect proportioning of the mature B cell 
populations in the λ5-/- mice. A detailed analysis of the different peripheral B cell 
compartments, their turnover and repopulation ability should help to address this 
question. 
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2.1 Addendum 
 
2.1.1 The hairpin opening activity 
 
The first hint to answer the question, which factor is responsible for opening 
hairpinned coding ends gave the analysis of a group of patients with T-B-SCID, 
characterized by the absence of T and B cells and an increased sensitivity to DNA 
damaging agents (RS-SCID) (Nicolas et al., 1998). This study together with the 
characterization of cells of A-SCID patients (a SCID variant with a very high 
incidence in Athabascan-speaking Navajo and Apache Native Americans) 
substantiated the idea of an additional, yet unknown NHEJ factor (Li et al., 1998). 
Soon it was discovered that RS-SCID and A–SCID are caused by the same genetic 
defect (Moshous et al., 2000). Involvement of the RAG1/2 genes as well as Ku80, 
Ku70, DNA-PKcs, ligase IV and XRCC4 had been ruled out in these patients by means 
of genetic linkage analysis of all known NHEJ factors (Li et al., 1998; Nicolas et al., 
1998), the A-SCID locus showing linkage to markers on chromosome 10p (Li et al., 
1998). Cells of these patients were shown to be deficient for V(D)J recombination, 
result of the failure in coding joint formation but not signal joint formation. This 
phenotype was remarkably similar to that seen in DNA-PKcs-deficient SCID mice, in 
which also hairpin coding ends accumulate. Eventually, the corresponding gene, 
termed Artemis, was identified and sequence analysis suggested that it belonged to the 
β-lactamase familiy (Moshous et al., 2001). Artemis was soon shown to posess single-
strand-specific 5’ to 3’ exonuclease activity and, upon complex formation with DNA-
PKcs and activation, also to acquire endonucleolytic activity on DNA overhangs and, 
most interestingly, also on hairpins (Ma et al., 2002). These properties strongly 
suggest that Artemis is the long sought hairpin opening activity, the V(D)J deficiency 
of Artemis-/- mice supporting this assumption (Rooney et al., 2002). The general role 
of Artemis in DNA repair is probably based on its exo- and endonucleolytic activities, 
processing DNA ends at DNA double strand breaks (DSBs) for NHEJ repair (Rooney 
et al., 2003).  
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2.1.2 The role of Nbs1 
 
The first critical step in the cellular response to DSBs is sensing the DNA lesions. In 
this process several factors are involved including the phosphatidylinositol 3-kinase 
like kinase (PIKK), like ATM, and Nbs1 as part of the Mre11/Rad50/Nbs1 (MRN) 
complex (Bakkenist and Kastan, 2003; Petrini and Stracker, 2003). Upon DSBs 
generated by irradiation ATM is activated, phosphorylating subsequently first itself 
and then a wide range of proteins functionally implicated in the genome integrity 
network, like the histone variant H2AX (resulting in γH2AX). The latter immediately 
forms discrete foci in response to DSBs and has been suggested to function as a 
scaffold for the assembly of protein complexes involved in the subsequent cellular 
responses (Fernandez-Capetillo et al., 2004). Nbs1, also phosphorylated by ATM (Wu 
et al., 2000), colocalizes with γH2AX (Kobayashi et al., 2002), thereby bringing in the 
other components of the MRN complex. But Nbs1 is not only involved as a 
downstream target of ATM, it has also been implicated in the modulation of ATM 
activation and thereby also of the general DNA repair response (Horejsi et al., 2004). 
Additionally, other DSB repair factors, like BRCA1, are recruited to the foci to 
subsequently initiate together critical downstream steps in the cellular response to 
DSB, i.e. either the activation of a cell cycle checkpoint to facilitate DNA repair or 
the induction of p53 mediated apoptosis. Nbs1 together with the MRN complex has 
been implicated in the intra-S phase and G2/M checkpoint, lying downstream of ATM 
(Buscemi et al., 2001; Falck et al., 2002). Additionally, the biochemical activities of 
Mre11 in the context of the ternary M/R/N complex are probably directly involved in 
the processing of DNA ends preparing them for DNA repair (D'Amours and Jackson, 
2002). Rad50, in turn, belongs to the family of structural maintenance proteins and 
has been suggested to bind to DNA ends and hold them in close proximity to facilitate 
religation (D'Amours and Jackson, 2002). Nbs1 as part of the MRN complex seems 
therefore to be involved in sensing DSBs, signaling of the induced cellular response 
as well as directly in the repair of DNA breaks.  
Originally, it was thought that the DSBs, generated during VDJ recombination, would 
not be detected by the cellular repair machinery, because of its sequestration into the 
postcleavage complexes by the RAG1/2 proteins (Agrawal and Schatz, 1997; Hiom 
and Gellert, 1998). However, it could be shown that the histone variant H2AX and 
Nbs1 form RAG dependent foci at the the TCRα locus (Chen et al., 2000), implying 
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the detection of the DSBs by the repair factors. The high frequency of chromosomal 
translocations involving the Ig and TCR loci seen in humans deficent in ATM, Nbs1 
or Mre11 (Kobayashi et al., 2004; Taylor et al., 2004) together with the increased 
inter-chromosomal V(D)J recombination in Nbs1 mutant mice (Kang et al., 2002) 
suggest additionally a link between V(D)J recombination and Nbs1 and the other 
DNA repair factors, even if they are not needed to perform the rearrangement. This 
has led to the proposal that RAG initiated DNA damage is sensed and generates 
signals to suppress oncogenic translocations. Additionally, H2AX and the MRN 
complex could function as an anchor for the assembly of DNA/protein complexes that 
prevent the dissociation and potential misrepair of the broken DNA ends at the DSBs.  
Class switch recombination (CSR) is a second genomic recombination reaction, that B 
lymphocytes can undergo in response to antigenic stimulation. This reaction replaces 
one Ig constant gene for another, thereby changing the effector function of the Ig. 
Interestingly, V(D)J recombination and CSR seem to have differential requirements 
for certain components of the cellular DSB response machinery. Although, Nbs1 and 
H2AX foci are formed during both processes (Chen et al., 2000; Petersen et al., 2001), 
only CSR is impaired in H2AX deficient mice (Celeste et al., 2002; Reina-San-Martin 
et al., 2003). Also Nbs1 is thought to be involved in CSR (Digweed and Sperling, 
2004; Pan et al., 2002), explaining the agammaglobulinaemia often seen in Nbs1 
patients (van Engelen et al., 2001). This differential requirement for DNA repair 
factors may reflect the fact that RAG liberated DNA ends are stably held and actively 
linked to downstream factors by the RAG proteins in the postcleavage complex. In 
contrast, DSBs initiated during CSR may not be similarly held by specific synapsis 
factors, depending therefore on factors, like the MRN complex, to tether the generated 
DNA ends in close proximity. 
Additionally, Nbs1 has been implicated in telomere maintenance (Lombard and 
Guarente, 2000; Ranganathan et al., 2001) as well as in meiotic recombination, 
together with Mre11 and Rad50 (Ivanov et al., 1992; Tsubouchi and Ogawa, 1998). 
Altogether, Nbs1 in a complex with Mre11 and Rad50 has been shown to be 
important in multiple cellular mechanisms maintaining genomic integrity of a cell. 
Concerning V(D)J recombination, as Nbs1 is not directly involved in the 
rearrangement mechanism, we did not detect any defect in the rearrangement process 
in cells of NBS patients. Nonetheless, there seems to be a residual dependence of 
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V(D)J recombination on Nbs1, a kind of additional backup system to ensure correct 
joining of the RAG associated DNA ends. Deficiency in any of the involved factors is 
not enough to result in an obvious defect in the cellular assays we employed, but 
suffices to cause the frequent chromosomal translocations of the Ig and TCR loci seen 
in NBS patients. 
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3 Targeting of the KRC locus 
 
Introduction 
 
KRC for Kappa B and RSS recognition component was identified in a screen for RSS 
binding proteins (Wu et al., 1993). The cDNA was cloned by searching a mouse 
thymocyte expression library with a DNA probe harboring alternating RSS heptamers 
and nonamers for proteins with RSS binding specificity. Also in nuclear extracts of B 
lymphocytes KRC was found to be the major RSS binding protein (Wu et al., 2001). 
Additionally, KRC was shown to bind the κB motif of the Ig κ light chain enhancer 
and related sequences.  
Molecular cloning and sequencing of the KRC cDNA identified long 5’- and 3’-
untranslated regions and a large open reading frame encoding nearly 2,300 amino 
acids. The deduced protein sequence revealed multiple DNA and protein-protein 
interaction domains. Most characteristic are the two ZAS domains which consist of 
tandem zinc fingers, followed by an acidic motif and a Ser/Thr-rich region. The ZAS 
domains are located at the C-terminus and at the N-terminus. Flanked by the two ZAS 
domains are a single zinc finger, an acidic motif, a Ser-rich region, a putative nuclear 
localization signal and several GTPase motifs (see figure 3.1, Wu et al., 1996). 
Both isolated ZAS domains were expressed as recombinant protein fragments and 
were shown to form ordered, multimeric complexes (Mak et al., 1994). It was also 
demonstrated that both ZAS domains  bind, independently of each other, the κB motif 
as well as the RSS (Mak et al., 1998; Wu et al., 1993). A site selection study 
performed on random nucleotide sequences with each of the two ZAS domains 
specifically selected RSS-like sequences (Allen et al., 2002a). 
 
 
 
 
 
 
Figure 3.1: Schematic representation of the KRC protein 
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Interestingly, the DNA binding properties of KRC are modulated by post-translational 
modifications. Bachmeyer and coworkers showed that preincubation of recombinant 
protein with nuclear, but not cytoplasmic, extract of a pre-B cell line increased DNA 
binding (Bachmeyer et al., 1999). Induction of V(D)J recombination decreases the 
affinity of KRC to the RSS (Hicar et al., 2002; Wu et al., 2001) making it conceivable 
that KRC is involved in V(D)J recombination either in the mechanism itself or its 
regulation through modifying its accessibility to the RSS.  
KRC is expressed most prominently in thymus and brain but also present in spleen 
and bone marrow (Hicar et al., 2002; Wu et al., 1996; Wu et al., 1993). Interestingly, 
multiple differential splicing transcripts were identified with a different splicing 
pattern in thymus and brain. The prevalent KRC transcripts in the thymus are the full 
length version and a spliced form lacking the second exon which includes ZAS1 and a 
significant portion of the middle part of KRC with the putative nuclear localization 
signal. In the brain the most abundant transcript lacks exon IV which comprises 
amongst other regions the ZAS2 domain (Mak et al., 1998). These alternative splicing 
events could result in the production of KRC isoforms with varying DNA and protein 
binding properties, suggesting that KRC may have different functions in lymphoid 
and neuronal tissues. 
One known function of KRC is its ability to positively regulate the transcription of the 
S100A4/mts1 gene, which is linked to its κB (and related motifs) binding specificity 
(Hjelmsoe et al., 2000). S100A4/mts1 is a small acidic Ca2+-binding protein which has 
been implicated in metastasis formation probably through its interaction with p53 
(Grigorian et al., 2001) and nonmuscle myosin (Kriajevska et al., 2000). S100A4/mts1 
was shown to be expressed, similarly to KRC, in lymphoid tissues (Ebralidze et al., 
1989) and in the central nervous system (Aberg and Kozlova, 2000).  
KRC, itself, has also been implicated in proliferation. Introduction of antisense KRC 
mRNA into HeLa cells resulted in lower protein expression levels, induced 
proliferation, anchorage independence growth and mitotic cell death (Allen and Wu, 
2000). If this observation is linked to the function of KRC as a positive transcriptional 
activator of the S100A4/mts1 gene is unknown. 
Additionally, to the regulatory function of KRC in gene expression, it was also shown 
that KRC participates directly in signaling events through protein-protein interactions. 
Altered expression of KRC modulates tumor necrosis factor α (TNF-α) driven 
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responses (Oukka et al., 2002). Overexpression of KRC inhibited, while antisense 
KRC c-DNA or a dominant negative form of the protein enhanced NFκB activation as 
well as Jun N-terminal kinase (JNK) phosphorylation and consequently apoptosis and 
cytokine expression. Regulation of the TNF-receptor downstream signaling seemed to 
occur via direct protein-protein interaction of KRC with TRAF2.  
KRC´s binding specificity to the RSS, but also its modulatory function of 
inflammatory and apoptotic responses seemed very interesting. Together with its 
lymphoid expression pattern it made it conceivable that KRC plays a role in lymphoid 
cells early on in development during V(D)J recombination and/or later during immune 
responses. To address this question we decided to generate KRC  deficient mice.  
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Results 
 
Cloning of the targeting construct 
 
The KRC locus spans over 70 kb genomic sequence and consists of 7 exons (Wu et 
al., 1996). Exon II is with its ca. 5.5 kb size extraordinarily large. It comprises the 
start codon together with the coding region for a significant portion of the protein 
including the first ZAS domain and the putative nuclear localization sequence. 
Therefore we designed a targeting vector which would lead, upon homologous 
recombination, to the deletion of nearly the complete coding region of exon II, 
encoding the N-terminal and central region of KRC, as well as part of exon III 
including the splice acceptor site to prevent splicing from exon I to III (see figure 3.2). 
 
 
Figure 3.2: Schematic representation of the targeting construct, genomic and targeted locus 
 
The targeting construct carried a neomycin resistance marker inside the targeting 
casssette as a positive selection marker. Additionally, for negative selection against 
randomly integrated DNA constructs the diphtheria toxin A expression cassette was 
placed beside the long arm of homology. Two homology regions flanked the targeting 
cassette. The 5’ homology region consisted of 1 kb of the upstream 5’ UTR of 
exon II. The 7 kb long 3’ homology region consisted of downstream intronic region of 
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exon III including the splice donor site of exon III. Both homology regions were 
cloned by PCR amplification with 129/Ola genomic DNA as template. The primers 
for the amplification of the 5’ arm could be readily designed based on the known 
sequence of exon II whereas the intronic sequence downstream of exon III was not 
known. Therefore the 3’ intronic sequence was assembled using an in silico genome 
walking approach (see methods 7.11).  
 
Targeting of the KRC  locus 
 
Targeting was done in the 129/Ola derived E14 ES cell line. ES cells were transfected 
with the linearized targeting construct and selected with G418. 450 resistant ES cell 
clones were screened by PCR for homologous integration of the construct first as 
pools of 8-10 clones and then the corresponding single clones. Screening PCR was 
designed to detect homologous integration of the short arm, with one primer lying 
upstream of the 5’ homology region in the genomic locus and the second lying in the 
construct. One positive ES cell clone was detected. Homologous integration was  
 
Figure 3.3: PCR Screening of G418 resistant ES cell clones. Upper part shows a schematic 
representation of the locus and the PCR strategy. Clone #57 positive for homologous 
recombination, clone #58 with random integration of the targeting construct. Lanes 1: clone 
#58; Lane 2: clone #57 Lane; Lane 3: WT DNA; Lane 4: no DNA; 5: standard. 
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verified with different primer combinations (see figure 3.3) and by additionally 
sequencing the complete amplificate of the screening PCR to exclude false positives. 
This targeted ES cell clone was injected into BDF1 blastocysts which were then 
transplanted into pseudopregnant females. 40 agouti offspring mice with varying 
degrees of chimerism, judging from fur colour, were born. Eventually various 
chimeric mice were bred to C57Bl/6 animals to obtain offspring of ES cell origin 
carrying the targeted locus. One of the chimeric mice gave germline transmission. The 
heterozygous offspring was then either intercrossed to obtain homozygous KRC 
knock-out mice or backcrossed with C57Bl/6 mice.  
 
Characterization of the Integration Event 
 
While heterozygous mice were bred the integration event was further genomically 
characterized. Southern blot analysis of the 5’ region of the targeted locus confirmed 
that the construct had homologously integrated with the short arm into the KRC  locus 
(see figure 3.4).  
 
 
 
 
Figure 3.4: Southern blot analysis of the targeting construct integration at the 5’ prime homology 
region. 
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In contrast, southern blot analysis of the 3’ region in the selected ES cell clone 
revealed that the long arm had not homologously but randomly integrated into the 
locus (see figure 3.5). Quantitation with Real Time PCR showed that the exonic 
region directly downstream of the 5’-homology region had not been deleted (Data not 
shown). Southern blot analysis of the intronic region between exon II and II showed 
no modification of this region (Data not shown).  
Altogether this suggested that the 3’-homology sequence had been joined to the 
genomic 5’-DNA end which was created during homologous recombination of the 
short targeting arm. Thereby exon II would not have been deleted. Nonetheless, one 
would expect that the integration event should interfere substantially with the 
transcription and translation of the locus. First of all, vector sequence is integrated 
into the locus which interrupts the KRC open reading frame. Additionally, the vector 
region include the neomycin resistance cassette which is transcribed in opposite 
direction to the locus thereby producing a kind of „antisense“ RNA. Furthermore, 
correct splicing should be hampered. The long homology region includes at its 5’ end 
the splice donor site of exon III. Therefore splicing should occur from exon I to the 
targeted start of exon II and then again from the 5’-end of the right homology arm 
with the splice donor site of exon III to the splice acceptor site of the genomic exon III 
omitting thereby the residual genomic region of exon II. 
 
Figure 3.5: Southern blot analysis of the 3’ prime region of the targeted locus with  a construct 
specific probe.  
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Southern blot analysis performed with construct specific oligonucleotides additionally 
detected a second integration event of the targeting construct (see figure 3.6). The fact 
that all heterozygous mice also carried the second integration led to the conclusion 
that the second integration occured on the same chromosome. Using an inverted PCR 
approach the 3’ site of the second integration could be localized to the first intron of 
the KRC locus itself, more precisely about 5 kb upstream of exon II. Judging on basis 
of the currently known features of this genomic region 
(www.ncbi.nlm.nih.gov/mapview/) and if no larger rearrangements or translocations 
took place the second integration should not affect any other gene than the KRC gene 
itself. The fact that germline transmission was seen also suggests that no major 
rearrangements on the chromosomal level took place.  
 
Figure 3.6: Southern blot analysis of the targeted locus with a construct specific probe. 
 
 
Developmental consequences of the targeted KRC locus 
 
Heterozygous mice were mated to obtain homozygous offspring for analysis of the 
effect of homozygosity of the targeted locus. We analyzed 44 3-week-old offspring of 
the heterozygous crosses and found no homozygous progeny. The average litter size 
was 5. One mouse died before weaning. Genotyping detected 9 WT and 35 
heterozygous mice. Altogether this suggested that homozygosity of the mutation was 
embryonically lethal. 
To investigate this question time matings were set up of heterozygous mice to analyze 
embryos at different timepoints of gestation. Embryos of day 14.5 pc ( n = 24) and 
day 11.5 pc (n =12 ) were analyzed by southern blotting (see figure 3.7). Embryos of 
day 9.5 pc were genotyped (n = 10) with PCR. No homozygous embryo could be 
detected. 
WT +/- 
7-8?  
 
 
4 
4 kb  
HindIII HindIII 
Targeted locus 
Hybridization probe 
vector specific DNA 
Genomic DNA  
Homology region HindIII 
Targeting of the KRC locus  
59 
 
Figure 3.7: Genotyping of embryos by southern blot analysis with an 5’ genomic probe.  
 
 
To determine wether the embryonic lethality was post- or preimplantational we 
analyzed 67 embryos of the blastocyst stage (3.5 dpc) with a nested PCR approach for 
the presence of homozygotes (see figure 3.8). We did not detect any homozygous 
embryos indicating either preimplantation or cell-autonomous lethality of the 
homozygous mutation.  
 
 
 
 
 
 
 
 
 
 
 
Figure 3.8: Genotyping 3.5 dpc blastocystes by nested PCR analysis, representatives results. 
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decided to analyze the lymphoid compartment of heterozygous mice to see if 
haploinsufficiency would lead to detectable defects in the heterozygotes.  
Therefore different lymphoid organs of 9 week old heterozygous mice (n = 4) were 
analyzed. Figures 3.9-11 show representative FACS analysis of the different organs 
and cell populations. In the thymus normal proportions of CD4+ and CD8+ DN, DP 
and SP thymocyte subpopulations were present. Also in the mesenteric lymph nodes 
no effect of heterozygosity on the CD4+ or CD8+ SP thymocyte populations was 
detected. The bone marrow contained a normal percentage of immature B220+/IgM+ 
and recirculating mature B220high/IgM+ B cells. Analysis of the CD19+ comparment of 
the spleen detected normal percentages of immature T1 (493+/CD23-), immature 
T2+T3 (493+/CD23+), follicular (CD21+/CD23+) and marginal zone B cells 
(CD21+/CD23-). In conclusion, no obvious defect was found in heterezygous animals. 
 
 
Figure 3.9: Representative FACS profiles of different organs of WT and heterozygous mice. The 
cells of all organs are gated on the lymphoid FSC and SSC gate. MLN = mesenteric lymph node 
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Figure 3.10: Representative FACS profiles of spleen cells of WT and heterozygous mice. The cells 
are gated on the lymphoid FSC and SSC gate and additionally on CD19+ cells. BM = bone 
marrow 
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Figure 3.11: Representative FACS profiles of peritoneal cells of WT and heterozygous mice. The 
cells are gated on the lymphoid FSC and SSC gate and additionally on CD19+ cells. PEC = 
peritoneal cells 
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Discussion 
 
KRC belongs to a family of large DNA binding proteins. Based on sequence 
similarities, these proteins are divided into three classes (Wu et al., 1993) represented 
by HIV-EP1 (also known as Schnurri-1, MBP-1, PRDII-BF1 and αA-CRYBP1), 
HIV-EP2 (also known as Schnurri-2, MBP-2, AGIE-BP1 and MIBP1) and KRC 
(Schnurri-3, HIV-EP3, KBP1). The different names are indicative of the large 
spectrum of functions the different protein family members are involved in. Human 
HIV-EP1 has been shown to activate transcription of the human immunodeficiency 
virus enhancer (human immunodeficiency virus type I enhancer binding protein 1) 
(Seeler et al., 1994). Its mouse counterpart αA-crystallin binding protein 1(αA-
CRYBP1) acts as transcription activator for the αA-crystallin gene during the 
development of the eye lens (Brady et al., 1995). The Drosophila orthologue Schnurri 
plays a role in dorsal ectodermal patterning as part of the decapentaplegic 
(Dpp)/TGF β signaling pathway (Arora et al., 1995; Grieder et al., 1995). HIV-EP2 in 
mouse has been shown to be required for positive selection of thymocytes (Takagi et 
al., 2001). This groups KRC into a protein family whose members are involved in 
diverse developmental processes including transcriptional regulation and signaling. 
Due to its lymphoid expression pattern and its RSS binding ability we wanted to 
further characterize the role of KRC in lymphocyte development including V(D)J 
recombination.  
To address this question we targeted the KRC locus. Targeting was done in 129/Ola 
ES cells and homologous recombination was tested by PCR screening and subsequent 
sequencing of the amplified products. One clone out of 450 was tested positive for 
homologous recombination. Closer characterization of the targeted locus verified the 
correct integration of the short homology region but also revealed random integration 
of the the long (3’-) homology region of the targeting construct. Integration of the 
targeting construct into the 5’ region of exon II presumably led to an interruption of 
transcription, translation and/or interference with the correct splicing of the KRC  
messenger RNA mimicking a deletion of exon II. Additionally, a second integration 
of the targeting construct into the first exon of the KRC locus was detected. Taken 
together these results argue for a successful disruption of the KRC locus.  
The clone positive for homologous recombination was injected into BDF1 blastocysts 
and these were subsequently transplanted into pseudopregnant females. Chimeric 
Targeting of the KRC locus  
 
64 
mice were backcrossed to C57BL/6 and the heterozygous offspring was subsequently 
intercrossed to allow homozygosity of the targeted KRC locus.  
The offspring was genotyped and none of the 44 tested littermates was homozygous 
for the targeted KRC locus indicating that homozygosity of the targeted locus led to 
embryonic lethality. We therefore genotyped embryos between day 9.5 pc and 14.5 pc 
of embryonic development. No homozygous embryos were detected, demonstrating 
that homozygosity of the targeted locus causes embryonic lethality bevore day 9.5 pc. 
To narrow down the time frame of embryonic lethality 3.5 dpc blastocysts were 
genotyped by PCR, but again no homozygous embryo was detected leading to the 
conclusion that homozygosity of the mutation causes either preimplantational or cell-
autonomous lethality.  
Preimplantational development of mouse embryos proceeds through a series of 
critical steps: the transtition from oocyte to embryo, the first cell divisions, the 
establishment of cellular contacts and the first lineage differentiation. Global 
expression profiles revealed two major waves of de novo transcription, one 
corresponding to the zygote gene activation and the second to the mid-preimplantation 
gene activation (Hamatani et al., 2004; Wang et al., 2004). These analysis also 
showed that mouse oocytes and early embryos (analyzed till blastocyst stage) express 
components of multiple signaling pathways like Wnt and Notch and most 
interestingly of the bone morphogenetic protein (BMP) signaling machinery. BMP 
signaling, involved in nearly all aspects of embryonic development and 
organogenesis, is in turn closely related to the Dpp signaling in Drosophila where the 
KRC orthologue Schnurri is part of (Zhao, 2003). Therefore it would be conceivable 
that KRC deficiency causes preimplantational lethality by interfering with essential 
signaling processes in the very-early embryo development. Alternatively, the 
implication of KRC in proliferative processes (Allen and Wu, 2000), demonstrated by 
its effect on the growth of HeLa cells, could have adverse effects on embryonic 
preimplantational development. Preimplantation lethality has been shown to occur, 
like in the case of the mixed lineage leukemia gene (MLL), which is involved in Hox 
gene regulation. MLL deficient embryos do not progress to the 2-cell stage in vivo  
(Ayton et al., 2001) only in vitro. 
Results published during the course of the project by Allen et al. would also argue 
against cell-autonomous lethality. In this report, 500 bp of the coding region of 
Targeting of the KRC locus  
65 
exon II were replaced with a neomycin resistance cassette (Allen et al., 2002b). 
Homozygous ES cell clones were generated by subjecting the heterozygous clones to 
more stringent G418 selection. These cells were then analyzed in a RAG2-/- blastocyst 
complementation system. The authors do not comment on why no heterozygous and 
subsequently homozygous mice were generated with the help of these ES cells. This 
suggests that while KRC deficient cells were viable also this targeting might have 
resulted in embryonic lethality. Analysis of the RAG2-/-;KRC-/- chimeras showed that 
B and T lymphocytes developed leading to the conclusion that KRC deficiency had no 
effect on V(D)J recombination. Nonetheless, it is noteworthy that only exon II was 
targeted in this approach leaving open the possibility that an isoform of the protein, 
excluding exon II, plays a role in V(D)J recombination, since it had been shown that 
especially the thymus naturally expressed such a splice variant (Mak et al., 1998). 
Although reconstitution of the lymphoid system took place in the RAG2-/-;KRC-/- 
chimeras, analysis of older chimeras revealed a marked deficit of CD4+/CD8+ double 
positive thymocytes. Since BMP signaling was also shown to be involved in T 
lymphocyte development one could speculate again about a correlation of KRC and 
BMP signaling (Graf et al., 2002; Hager-Theodorides et al., 2002). 
Furthermore, Oukka et al. published a report in which they characterized KRC 
deficient T cells and showed that KRC is involved in the regulation of the IL-2 gene 
in T cells via interaction with c-Jun (Oukka et al., 2004). As this report referred to 
unpublished data regarding the generation of the analyzed cells it is unclear what kind 
of targeting approach the authors chose and if it caused embryonic lethality.  
Taken toghether, the results of this work suggested that complete disruption of the 
KRC gene locus leads to very early embryonic lethality, provided that no other 
essential genes were affected by the targeting.  
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4 Analysis of the mature B cell compartments in λ5 
deficient mice  
 
Introduction 
 
Developing B lymphocytes rearrange their V, sometimes D and J segments of their 
IgH and L chain gene loci in an ordered, stepwise fashion (Alt et al., 1984; ten Boekel 
et al., 1995; ten Boekel et al., 1998). The first segments to be rearranged at the 
transition of the proB cell to the preB-I cell stage are the DH and JH gene segments of 
the IgH locus. Both IgH alleles are rearranged resulting in preB-I cells carrying two 
IgH DJ rearrangements. Late stage preB-I cells start to rearrange VH to DJH, first only 
on one allele. If the VH to DJH rearrangement is productive and the resulting µH 
protein is able to pair with the surrogate light chain (SL) a pre-Bcell receptor 
(preBCR) is formed and expressed on the cell surface. The SL is composed of the 
noncovalently associated VpreB and λ5 proteins, forming a λL-chain-like structure 
that is able to pair and form disulfide bridges with µH chains. Only if a non-
productive rearrangement occurs on the first allele or if the synthesized µH protein is 
unable to pair with the SL, will the second allele be rearranged. Thus, it is ensured 
that a single B cell expresses only one type of IgH on the cell surface (Nussenzweig et 
al., 1987), a phenomenon termed allelic exclusion. Deposition of a preBCR on the cell 
surface allows the cells to become large preB-II cells which undergo two to five 
rounds of cell division (Rolink et al., 2000). Thereby, only clones with a SL pairing 
µH are expanded, whereas other cells with nonpairing µH chains are not. Successful 
pairing with the SL could therefore be seen as a µH quality control checkpoint. 
Eventually, the cells become small resting preB-II cells, rearranging their κL and/or 
λL chain loci. In the case of a productive L chain rearrangement cells develop into 
surface IgM-bearing immature B cells. These sIgM+ B cells, after having been 
negatively selected against autoreactive cells, leave the bone marrow and home to the 
spleen. There they go through different phenotypically characterized stages of the 
transitional compartment finally becoming mature B cells (reviewed in Rolink et al., 
2004). The most prominent mature B cells in the spleen are the follicular B cells, 
mainly involved in thymus-dependent (TD) immune responses. Marginal zone B 
(MZB) cells, located at the outer rim of the follicles, represent a smaller fraction of 
splenic B cells, their origin being still a matter of debate (Lopes-Carvalho and 
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Kearney, 2004; Martin and Kearney, 2002). They are considered to be a first line of 
defense against blood-borne antigens (Martin et al., 2001) participating in TI immune 
responses. Another peripheral mature B cell population, the B1 B cells, represents in 
the spleen only a minor fraction, but is the main B cell population in peritoneal and 
pleural cavities. B1 B cells develop prior to weaning and persist thereafter, in contrast 
to conventional B2 B cells, as a self-replenishing population. Two subpopulations are 
differentiated based on their CD5 expression, the B1a being CD5+ and the B1b CD5–
/low. A high proportion of the serum IgM, including the natural antibodies (produced 
without apparent antigenic stimulus) is produced by the B1 B cells. They are thought 
to participate mainly in thymus-independent (TI) immune responses (Herzenberg, 
2000).  
Several mutations affecting the early development of B cells are known. In 1992 
Kitamura and coworkers generated λ5 deficient mice to analyze the role of the SL 
component in B cell development. λ5-/- mice, also referred to as λ5T mice, showed, as 
expected, a block in early B cell development, more precisely at the transition from 
preB-I cells to preB-II cells. In contrast to other deficiencies for e.g. like in the µMT 
mutant mice, in which the exon encoding the transmembrane domain of the µH chain 
was disrupted (Kitamura et al., 1991), the developmental block observed in λ5-/- mice 
was incomplete. As a consequence cells of the following developmental stages were 
largely reduced but not completely absent and a low number of B2 cells could be 
detected in the periphery. These cells were shown to be functional concerning their 
ability to respond to TD as well as TI immunizations. Analysis of the B1 B cell 
compartment revealed, apart from an initial reduction of cell numbers in neonates, no 
significant differences to wild type mice.  
In the past few years many new phenotypic markers and marker combinations have 
been characterized allowing to distinguish B cell populations like transitional B cells 
or MZB by flow cytometric means. In 1992 these marker combinations were not yet 
known and as a consequence, no detailed analysis of the different B cell 
compartments in the λ5-/- mice could be made. Several different mice with mutations 
affecting the generation of B cells have been characterized, also concerning their 
mature B cell populations. Thereby it became apparent that a whole variety of 
molecules are involved in the shaping of the mature B cell pool. Thus, mutations 
affecting the BCR co-receptors, BCR signaling regulators or Notch signaling 
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pathways influence the formation of a mature B cell populations in different ways. 
Interestingly, it was observed that there is a tendency to preferentially propagate and 
maintain activated and/or highly responsive cells, like MZB, in B lymphopenic mice 
(Carvalho et al., 2001; Hao and Rajewsky, 2001).  
This raised the question whether λ5 deficient animals would also show a proportional 
expansion of B cell compartments, considered to be more innate. To address this we 
decided to analyze B cell populations in λ5 deficient mice in more detail. 
Additionally, we studied the turnover of the different B cell populations in wild type 
and mutant mice, the secondary immune response and the ability of λ5-/- progenitor 
cells to reconstitute in competition with wild type cells in mixed bone marrow 
chimeras.  
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Results 
 
Characterization of B cell populations in λ5 deficient mice 
 
B cell compartments in bone marrow, peritoneal cavity and spleen of adult wild type 
and λ5 deficient mice were analyzed by flow cytometry.  
As it was previously described (Kitamura et al., 1992; Rolink et al., 1994), analysis of 
the c-kit+/B220+ compartment in the bone marrow, comprising the early pre/pro-B, 
pro-B and pre-BI cells, showed a slight enlargement in λ5-/- mice compared to wild 
type (see figure 4.1 A). This was most probably due to the block in development at 
the transition of the pre-BI cell to the pre-BII cell, resulting in the accumulation of c–
kit+/B220+ cells. As a consequence of the block there was a pronounced decrease of 
the following pre-BII compartment (B220+/CD25+) (see figure 4.1). Also the 
IgM+/B220+ B cell fraction comprising the immature (IgM+/B220int) and mature 
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Figure 4.1: Representative flow cytometric analysis (A) and total cell numbers (B) of bone 
marrow viable cells of 9 week old wild type and λ5-/- mice. A) In the CD25 panel  only CD19+ 
lymphocytes are shown. Numbers indicate percentages of the subpopulations. B) Numbers 
above the bars indicate the x-fold difference in wild type and λ5-/- mice (n = 6 each group). 
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recirculating (IgM+/B220+) B cells was markedly reduced (see figure 4.1). Overall 
there was a 6.5 fold reduction of the number of CD19+/B220+ B cells in the bone 
marrow of mutant mice due to λ5 deficiency (see figure 4.1).  
As the developmental block in λ5 deficient mice is not absolute a low number of B 
cells were detectable in the periphery. Analysis of peritoneal cells in λ5 deficient mice 
revealed, as described by Kitamura and coworkers (Kitamura et al., 1992), a marked 
reduction but not complete absence of the CD5-/CD23+/B220+/CD19+ B 2 
compartment (see figure 4.2). The CD5+/B220int B1a population, which seems to be 
less dependent on the preBCR (Kitamura et al., 1992), was present in normal numbers 
in the adult λ5-/- mice (see figure 4.2 A/D). Instead the CD5low/B220int B1b population, 
though normal in relative proportion, was reduced about twofold in terms of total cell 
numbers in mutant animals (see figure 4.2 A/C/D).  
 
 
Figure 4.2: Analysis of peritoneal lymphocytes of 9 week old wild type and λ5-/- mice. A) and B) 
representative flow cytometric analysis. Only CD19+ cells are shown. Numbers indicate 
percentages of the subpopulations. C) and D) Relative proportions and total cell numbers of 
different B cell populations in the peritoneal cavity. Numbers above the bars in D) indicate the x–
fold difference in wild type and λ5-/- mice (n = 6 each group).  
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Analysis of the transitional B cell compartment in the spleen showed that T1 
(CD19+/493+/CD23-) as well as T2/T3 cells (CD19+/493+/CD23+) were barely 
detectable (see figure 4.3 A/C/D). Also follicular B (FOB) cells (CD19+/493-/CD23+) 
were proportionally and absolutely very much reduced (see figure 4.3 A/C/D). In 
contrast there was a relative increase of MZB cells in the CD19+ compartment in λ5-/- 
mice (see figure 4.3 B/C; CD19+/493-/CD23-/low/CD21high), but in terms of absolute 
numbers MZB cells were present in equal quantities in wild type and λ5 deficient 
mice (see figure 4.3 D). Phenotypically the MZB cells in λ5-/- mice showed a slightly 
reduced CD21 expression. The CD21low/CD23- B cell population (see figure 4.3 B), 
apparently proportionally enriched in the λ5-/- mice, has not yet been described before 
and is currently characterized phenotypically and functionally in our group. 
Figure 4.3: Analysis of splenic lymphocytes of 9 week old wild type and λ5-/- mice. A) and B) 
representative flow cytometric analysis of spleenocytes. Only CD19+ cells are shown. Numbers 
indicate percentages of the subpopulations. Relative proportions (C) and total cell numbers (D) of 
different B cell populations in the spleen. Numbers above the bars in D) indicate the x-fold 
difference (n = 6 each group).  
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To corroborate the proportional differences between the mature B cell populations in 
mutant λ5-/- and control mice we performed histological examination of spleen 
sections. Sections were stained for Thy-1+ T cells, IgM+ B cells and, to delineate the 
border between the marginal zone and the follicular area, MOMA-1+ metallophilic 
macrophages (see figures 4.4). In general, the size of follicles was smaller in λ5 
deficient animals than in control mice, corresponding to the reduced number of B 
cells. Especially the follicular area was diminished, in accordance with the lower FOB 
numbers, whereas the rim of marginal zone B cells was broadened reflecting the 
proportional increase of MZBs. Interestingly, we observed an elevated number of 
(bright IgM+) plasmablasts outside the follicles splenic sections of λ5 deficient mice 
without prior immunization of the mice (see figure 4.4 B/D).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4: Representative spleen section of wild type and λ5-/- mice. Sections were stained with 
anti-Thy1.1 (green), anti-IgM (red) and anti-MOMA-1 (blue). Arrows indicate plasma cells. 
 A  B 
 C  
D
 
Analysis of the mature B cell compartments in λ5 deficient mice 
 
76 
Turnover of mature peripheral B cells in λ5 deficient mice 
 
To assess the turnover of mature B cell populations in λ5 deficient and control 
animals, mice were injected i.p. with the thymidine analogon BrdU and thereafter fed 
with drinking water containing BrdU for 11 days. BrdU incorporation into the DNA 
of splenic and peritoneal B cell populations was determined at day 4 and 11 during 
BrdU feeding and day 10 and 28 of the chase period (n = 3 each group).  
Transitional B cells in wild type mice showed, in agreement with previously 
published data (Rolink et al., 1998), fast BrdU labeling which rapidly disappeared in 
the chase period indicating a high turnover of the cells (see figure 4.5 A). The lag in 
labeling of the T2/3 population compared to the T1 cells reflects the developmental 
chronology. Analysis of the BrdU labeling in the λ5-/- mice of transitional populations 
was omitted due to the low numbers of these cells.   
BrdU labeling of the FOB cell population occured at a rate of about 1% per day in 
WT mice (see figure 4.5 B). In contrast, the labeling rate of FOB cells in λ5-/- mice 
was only 0.5% per day, suggesting that FOB have a slower turnover in the mutant 
mice. The slower labeling kinetic was probably due to the largely diminished number 
of newly formed BrdU+ B cells entering the pool of FOB cells.  
Analysis of the MZB cell compartment in wild type mice showed a labeling kinetic of 
about 6% per day (see figure 4.5 C), probably as a result of influx of BrdU+ cells as 
well as proliferation in the MZB population. In comparison to the wild type, only 2% 
of the MZB cells in the λ5 deficient animals were labeled per day, probably due to a 
lowered influx of new BrdU+ cells into the compartment thereby reducing competition 
and consequently turnover of the cells.  
Labeling kinetics of the self-replenishing peritoneal B1a population showed basically 
no differences between mutant and wild type mice with a labeling of about 4% of the 
cells per day and a slower decay of BrdU+ cells during the chase period (see figure 4.5 
D). Analysis of the CD19+/CD5-/low population, comprising the conventional B2 B as 
well as B1b cells, showed very similar labeling kinetics in λ5 deficient and wild type 
mice (see figure 4.5 E). The cells were labeled at about 1.5% per day, a large fraction 
of them being B1b cells in the λ5-/- mice.  
Comparing the labeling kinetics in λ5 deficient mice and wild type mice it was 
evident that splenic B cell populations differed in their turnover of cells, being slower 
in the mutant mice, probably due to a reduced influx of newly formed B cells. Instead, 
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peritoneal cells of wild type and λ5-/- origin showed very similar labeling kinetics and 
turnover. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.5: BrdU labeling of splenic and peritoneal B cell populations in wild type and λ5 
deficient mice. Cells were stained with phenotypic markers to distinguish A) transitional T1 and 
T2/3, B) follicular B cells, C) marginal zone B cells, D) peritoneal B1a cells and E) peritoneal 
CD5- B cells i.e. B2 and B1b cells. BrdU+ cells were detected with an intracellular anti-BrdU 
staining. Represented are the means of the results of 3 wild type and λ5-/- mice per timepoint. 
Bars represent the standard deviation.  
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Humoral primary and secondary immune responses in λ5 deficient mice 
 
To investigate the influence of λ5 deficiency on primary and especially secondary 
immune responses, mice were immunized with the TD NIP-ovalbumin (s.c. with 
Freund´s adjuvant) or the TI type 2 antigen NIP conjugated to Ficoll (i.v. in PBS). 
Nearly 4 months after the first immunization the TD immunized mice received a 
second dose of NIP-ovalbumin.  
Hapten-specific antibodies of various isotypes and total IgM and IgG levels were 
determined in the sera of the mice at different timepoints before immunization, during 
the course of the primary immune response, after 2 month and 1 week after the 
secondary immunization.  
Analysis of the total IgM levels during the TD response showed an approximately 
twofold higher IgM concentration in the λ5-/- mice than in wild type controls, 
irrespective of the timepoint analyzed (see figure 4.6 A). The higher levels of IgM in 
λ5 deficient animals might have originated from the increased number of plasma cells 
seen in the histological sections of non-immunized mice (see figure 4.4). In contrast, 
total IgG levels were lower in λ5 deficient animals, most likely as a result of the 
decreased number of FOB cells (see figure 4.6 B). The amount of NIP specific IgM 
antibodies after TD immunization were higher in λ5 deficient animals than in the 
controls but this probably rather reflected the increased steady state IgM levels in λ5 
mutant mice than an elicited anti-NIP IgM response (see figure 4.6 C). Levels of NIP 
specific IgG instead were, after TD immunization, two- to threefold lower in the 
mutant mice (see figure 4.6 D), most probably due to the reduction of FOB cell 
numbers. This was presumably also the reason for the lower anti-NIP IgG1 as well as 
IgG2b and IgG2a TD response in λ5 deficient mice (see figure 4.6 E/F and 4.7 A). 
Upon TD immunization we could hardly detect any IgG3 response in control or in 
mutant animals (see figure 4.7 B). Reduced levels of the specific IgG responses (see 
figure 4.6 D/E/F and 4.7 A, between 2-5 fold reduction of the primary response) 
correlate with the about 5 fold reduction in number of B cells (see figure 4.3). Thus, 
the data indicate that λ5 deficient animals are able to make a TD primary as well as 
secondary immune response, although at reduced levels compared to wild type 
animals.  
 
Analysis of the mature B cell compartments in λ5 deficient mice  
79 
 
 
 
 
 
Figure 4.6: Total IgM (A) and IgG (B) concentrations in the sera of TD immunized wild type and 
λ5-/- mice. NIP specific IgM (C) , IgG (D), IgG1 (E) and IgG2b (F) levels in the sera of TD 
immunized wild type and λ5-/- mice. The measurements are given in relative units of dilution. 
Squares represent serum Ig concentrations of single wild type and circles of single λ5-/- mice. 
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Figure 4.7: NIP specific IgG2a (A) and IgG3 (B) levels in the sera of TD immunized wild type and 
λ5-/- mice. The measurements are given in relative units of dilution. Squares represent serum Ig 
levels of single wild type and circles of single λ5-/- mice. 
 
 
To further characterize the TD immune response in λ5 deficient mice germinal center 
formation was examined in mutant and wild type mice after the secondary 
immunization. Germinal centers are typical structures formed in secondary lymphoid 
organs during the course of a TD immune response. They are the place where affinity 
maturation, class switching and memory cell formation takes place. After the 
secondary TD immunization the animals were sacrificed, spleen sections were taken 
and stained for Thy-1+ T cells, IgM+ B cells and with peanut agglutinin for the 
presence of germinal centers (see figure 4.8). The sections clearly showed germinal 
center formation in λ5 deficient animals but in reduced number and size, 
corresponding to the data of the humoral TD immune response.  
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Figure 4.8: Representative spleen sections of wild type and λ5-/- NIP immunized mice. Sections 
were stained with anti-Thy1.1 (green), anti-IgM (red) and with peanut agglutinin for germinal 
center cells (blue). IgM and peanut agglutinin double positive cells are represented in pink. 
 
 
λ5 deficient mice were also characterized regarding their ability to respond to a TI 
type 2 antigen. Total IgM and IgG levels were measured during the TI response, again 
showing higher total IgM levels and lower total IgG levels in the mutant animals in 
comparison to control mice (see figure 4.9 A/B). In terms of NIP specific IgM 
responses, there was a 2-3 fold reduction in the λ5 deficient mice compared to the 
controls (see figure 4.9 C). Furthermore, the anti-NIP IgG, IgG1 and IgG3 (see figure 
4.9 D/E/F) responses were decreased in the mutant mice. B1 B and MZB cells are 
thought to be a major source of IgM (Martin et al., 2001) and MZB cells were shown 
to readily secrete IgG3 (Oliver et al., 1997). But even though the B1a and MZB cells 
were present in normal numbers in the λ5-/- mice, the animals showed a reduced TI 
response. Possibly the fact that the mice were immunized with soluble NIP-Ficoll 
skewed the TI type 2 response into other compartments like the FOB (van den 
Eertwegh et al., 1992), since MZB cells are known to respond to particulate antigens 
(Martin et al., 2001).  
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Altogether, these data indicate that λ5 deficient animals can mount TI as well TD 
immune responses including secondary responses, albeit at somewhat reduced levels 
most probably due to the diminished numbers of follicular B and/or B1b cells.  
 
Figure 4.9: Total IgM (A) and IgG (B) and NIP specific IgM (C), IgG (D), IgG1 (E) and IgG3 (F) 
levels in the sera of TI immunized wild type and λ5-/- mice. Squares represent serum Ig levels of 
single wild type and circles of single λ5-/- mice. The measurements in C-F are given in relative 
units of dilution. 
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Wild type and λ5-/- mixed bone marrow chimeras 
 
To assess the ability of λ5 deficient cells to reconstitute in competition with wild type 
cells, bone marrow cells of wild type (Ly5.1+) and λ5-/- (Ly5.2+) origin were 
transferred into sublethally irradiated RAG2-/- (450 rad) hosts. As control, mice were 
also reconstituted with either wild type or λ5-/- cells alone. Four and a half weeks later 
the mice were analyzed for reconstitution of T and B cell compartments and the 
relative contribution of wild type and λ5-/- cells. Unluckily, at that timepoint the mice 
started to become sick, probably due to a lack of regulatory T cells (A. Rolink 
personal comunication), so that the data should be considered preliminary until 
experiments will be repeated with newborn mice as hosts.  
Figure 4.10 A and B show the flow cytometric analysis of the T cell compartment in 
thymus and spleen. Phenotypical analysis of the organs showed normal T cell 
compartments in all three groups indicating successfull reconstitution. Around 3 
quarters of the T cells in the spleens of the mixed bone marrow chimeras were of λ5 
deficient origin (data not shown). This ratio probably reflected the relative 
contribution to reconstitution of λ5-/- cells to compartments not affected by λ5 
deficiency. Analysis of splenic B cells in the wild type and the mixed bone marrow 
chimeras showed reconstitution also of the B cell compartments. A slight proportional 
enlargement of the MZB cells compartment compared to normal mice was detected 
(see figure 4.10 A/B). Mice, which had received bone marrow only of λ5 deficient 
mice, also showed reconstitution of splenic B cell populations, albeit at largely 
reduced levels. A large proportion of the cells showed a MZB like phenotype 
although with a slightly reduced CD21 expression (see figure 4.10 C).  
Analysis of the mature B cell compartments in λ5 deficient mice 
 
84 
 
 
Figure 4.10: Representative FACS profiles of thymus (A) and spleen (B+C) of irradiated RAG-2-/- 
mice reconstituted with WT, λ5-/- or a 1:1 mixture of bone marrow. All profiles are gated on the 
lymphoid cells. C is additionally gated on CD19+ cells. Representatives profiles of the analysis 4-5 
mice each group.  
 
Analysis of the transferred cells concerning their origin showed that in the mixed bone 
marrow chimeras Ly5.1+ wild type cells mostly were CD21+/CD23+ i.e. FOB or T2/T3 
cells. Around 20% of the CD19+/Ly5.1+ cells showed a MZB phenotype (see figure 
4.11 B). The Ly5.2+ λ5 deficient cells instead adopted mostly a MZB cell like 
phenotype. Closer characterization of the cells showed that they were large in size, 
CD9+/low like typical MZBs but slightly lower in IgM and CD21 expression (data not 
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shown). The overall contribution of λ5 deficient B cells to the splenic B cell 
compartment was about 10-12% which has to be seen in the context of the relative 
BM contributions of wild type and λ5-/- being 1:3, based on analysis of the peripheral 
T cell compartment (see above).  
Figure 4.11: Representative FACS profiles of spleen (B/C) of mice reconstituted with WT (A), λ5–
/- (B) or a 1:1 mixture (C) of bone marrow. Profiles are gated on the lymphoid FSC/SSC gate. 
Representatives of the analysis 4-5 mice each group.  
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Additionally, spleens of mixed bone marrow chimeras were examined histologically 
to characterize the transferred cells also with regard to their splenic localization. The 
sections were stained for Thy1.1+ T cells, IgM+ B cells and Ly5.1+ or Ly5.2+ (see 
figure 4.12 and 4.13 A). To better define the MZB cells, the sections were stained 
with anti-IgM, anti-Ly5.1 or anti-Ly5.2 and additionally for MOMA-1+ cells (see 
figure 4.13 B/C). The ratio of Ly5.1+ to Ly5.2+ T cells corresponded to the 1:3 ratio of 
wild type to λ5 deficient T cells detected by flow cytometry (see figure 4.12 and 4.13 
A). The predominance of Ly5.1+/IgM+ cells in the follicular region was also obvious 
(see figure 4.12 and 4.13). Enrichment of Ly5.2+/Ly5.1- and IgM+ cells in the 
marginal zone instead was not so pronounced but still detectable (see figure 4.12+ and 
4.13, indicated with arrows). Splenic architecture, in particular the follicular 
structures, were altered in these mice so that often it was difficult to define clear 
marginal zones. However, the partial localization of λ5 deficient Ly5.2+ cells in the 
outer rim of follicles is in accordance with the MZB like phenotype of these cells 
determined by flow cytometric analysis. 
The data therefore suggest that λ5 deficient cells can participate to some limited 
extent in the reconstitution of the mature B cell pool being channelled mostly into the 
MZB compartment. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.12: Localization of cells of wild type and λ5-/- origin in spleen sections of mixed bone 
marrow chimeras. Sections were stained with anti-Thy1.1 (blue), anti-IgM (red) and anti-Ly5.1. 
IgM and Ly5.1 double positive cells are represented in yellow. Thy1.1 and Ly5.1 double positive 
cells are represented in cyan.  Arrows indicate the presence of Ly5.1-/IgM+ cells in the marginal 
zone. 
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Figure 4.13: Localization of cells of wild type and λ5-/- origin in spleen sections of mixed bone 
marrow chimeras. Sections were stained with anti-Thy1.1 (blue), anti-IgM (red) and anti-Ly5.2 
(A). Sections were also stained with anti-MOMA-1 (blue), anti-IgM (red) and anti-Ly5.2 (B) or 
anti-Ly5.1 (C). Thy1.1 and Ly5.2 double positive cells are represented in cyan (A). IgM and 
Ly5.1 (B) or Ly5.2 (A,C) double positive cells are represented in yellow. Arrows indicate the 
presence of Ly5.2+/IgM+ cells in the marginal zone.  
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Discussion 
 
At the time Kitamura et al. targeted the λ5 locus, the prediction would have been that 
B cells would be completely absent like in the µMT mice. However, analysis of the 
mutant mice revealed that the block in B cell development is not absolute and that 
mature B cells are found in the periphery. It was also shown that λ5 deficient B cells 
still do allelically exclude at their Ig locus (Kitamura et al., 1992), although there is 
some debate about this subject (Loffert et al., 1996). Allelic exclusion at the Ig locus 
was also shown for a double knockout mouse which lacked both of the structurally 
very similar and partially redundant VpreB proteins (Mundt et al., 2001), VpreB1 and 
VpreB2 (Martensson et al., 1999). Finally, also the triple deficient mice lacking all 
components of the SL, showed the same phenotype (Shimizu et al., 2002). These 
results suggested that even though B cell generation is impaired in a SL deficient 
situation there seems to be a preBCR-independent mechanism allowing the 
maturation but not proliferative expansion of a small numer of cells. This rescue 
mechanism is dependent on the membrane insertion of the µH since in µMT mice the 
developmental block is complete and in B cells heterozygous for the µMT mutation 
allelic exclusion is lost. Recently two reports showed that a certain transgenic µH can 
be expressed on the cell surface of preB cells in the absence of SL components and 
thereby promote IL-7 dependent growth and differentiation of preB cells (Galler et al., 
2004; Schuh et al., 2003) as well as the downregulation of TdT and the RAG proteins. 
Additionally, endogenous µH expression on CD19+ (SL-) BM cells of triple knockout 
mice could be detected showing that SL-independent µH chain surface expression is 
also possible in a non-transgenic situation (Galler et al., 2004.) This could possibly 
represent the mechanism allowing the development of the B cells seen in the SL 
mutant mice. Generation of B cells would then depend on the frequency of µH chains 
that can be expressed on the surface without associated SL. The mechanism by which 
a µH can be expressed on the cell surface without associating with the SL remains 
completely unclear. 
Due to the developmental block early in B cell development, the peritoneum of λ5 
deficient animals contained almost no conventional B2 B cells. In contrast, the B1a 
cells were present in the peritoneal cavity in normal numbers in adult mutant mice. 
Also the turnover of B1a cells, judged by BrdU labeling kinetics, was very similar in 
mutant and wild type animals. Experimental data suggest that B1 B cells are derived 
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from different progenitors than conventional B2 cells (reviewed in (Herzenberg, 
2000). They are formed early during ontogeny prior to weaning and persist thereafter 
as a self-replenishing population. Adult bone marrow fails to generate significant 
numbers of B1 cells. Several mutations, like e.g. IL7 deficiency, leading to a block in 
early B cell development in adult mice compromise formation of B2 B cells but still 
allow development of a normal B1 compartment (Carvalho et al., 2001). Also the VH 
repertoire in B1 cells differs from the adult B2 VH repertoire and the joining regions 
show less N-region insertion in B1 B cells. Wasserman and coworkers published data 
in which they showed that in fetal pre-B cells proliferation was rather inhibited by 
IgH transgenes efficiently forming a preBCR whereas expression of a fetal VH11 IgH 
transgene associating only imcompletely with the SL, promoted pre-B cell 
development in fetal stages but not in adult stages (Wasserman et al., 1998). This 
would suggest that B1 B cell generation is either less or not at all preBCR dependent 
explaining why B1 B cells develop nearly normally in λ5 deficient animals as well as 
in the triple knockout mice lacking all the SL components. This PreBCR-independent 
µH expression could be part of a mechanism that favors expression of a pure 
germline-encoded primordial repertoire biased toward certain specificities that bind 
for e.g. to common non-protein antigens as is seen in the B1 compartment. On the 
other hand, there is a time lag in the development of the B1 compartment in SL 
mutants arguing nonetheless for a role of the SL in B1 development. Additionally, the 
in vitro differentiation and proliferation potential of ex vivo isolated fetal liver preB-I 
is comparable to that of mature bone marrow preB-I (Rolink et al., 2000). λ5 
deficiency leads to strongly reduced survival, proliferation as well as differentation in 
this in vitro system irrespectively wether the preB-I cells are of fetal or adult origin. 
This would implicate the preBCR also in fetal B cell development. The fact that the 
B1 compartment is nearly of normal size in λ5 deficient animals would then rather be 
due to the self-replenishing capacity of B1 cells filling up their compartment by 
proliferation of a few initially generated cells.  
B1 B cells can be further differentiated into CD5+ B1a cells and CD5low/- B1b cells 
(Herzenberg, 2000).  B1a and B1b are very similar nonetheless there is evidence 
accumulating that these cells constitute different lineages. B1b cells have been shown 
to be reconstituted to some extent by adult bone marrow whereas B1a are not. 
Additionally, adoptive transfer of B1a cells mainly reconstitutes the B1a compartment 
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whereas transferred B1b cells mostly remain B1b cells. Analysis of the peritoneal B1 
compartment in λ5 deficient mice showed a twofold reduction of B1b cells. It would 
be conceivable that in adult mice there is still some bone marrow influx into the B1b 
population, which is very much reduced in λ5 deficient mice resulting in a smaller 
B1b compartment. Alternatively, the B1b cells are more dependent on the preBCR 
during their development than B1a.  
Analysis of the mature B cell populations in the spleen revealed a large reduction of 
FOB cells as a result of the impaired generation of B cells in λ5-/- mice. The turnover 
of cells was slower, probably due to the diminished influx of newly formed B cells. In 
contrast, there was a proportional, but not absolute, increase in the MZB 
compartment. The turnover of these cells was reduced suggesting that also the MZB 
compartment was affected by the diminished generation of B cells in λ5 deficient 
mice. Origin and selection of MZB cells is still a matter of an ongoing debate (Lopes-
Carvalho and Kearney, 2004; Saito et al., 2003). Some authors suggest that MZB are 
derived from the transitional compartment (Saito et al., 2003) others that they 
originate from FOB and/or memory B cells (Lopes-Carvalho and Kearney, 2004; 
Vinuesa et al., 2003). Interestingly, in B lymphopenic mice, for e.g. in animals in 
which B cell development is restricted to the perinatal period, the MZB compartment 
is often less or not affected at all (Carvalho et al., 2001; Hao and Rajewsky, 2001). 
This could be a result of the abundance of resources like growth factors, ligands for 
costimulatory and adhesion molecules etc. driving the cells into the “effector” branch 
of the B-cell system. In mice transgenic for the B cell survival factor BAFF (B- cell 
activating factor), for example, there is an particularly enlarged MZB compartment 
(Batten et al., 2000). Antigen, either self or environmental, has also been implicated in 
MZB enrichment (Julien et al., 2002). Enhanced antigenic selection could therefore be 
an alternative/additional mechanism leading to preferential selection of B cells into 
the MZB compartment. Reduced intercellular competition for antigens in 
B lymphopenic mice or lack of housekeeping Igs masking antigens could lead to 
enhanced antigen availability. Thus, experimental data showed that administration of 
polyclonal IgM to mice deficient in serum IgM reversed an observed MZB cell 
expansion in these mutant mice (Baker and Ehrenstein, 2002). Mutations affecting 
BCR-signaling properties are also known to influence the size of the MZB and FOB 
compartment differently (Martin and Kearney, 2002) substantiating that the selection 
Analysis of the mature B cell compartments in λ5 deficient mice  
91 
mechanisms are at least partially based on received BCR signals. Abundance of 
resources and/or antigens could therefore be an explanation why λ5 deficient mice 
generate a proportionally enlarged MZB compartment.  
On the other hand, an intrinsic propensity of λ5 deficient cells to develop into MZB 
was observed in the analyzed mixed bone marrow chimeras. This disposition was also 
observed when wild type cells were cotransferred with the λ5-/- cells, making 
abundance of antigens and resources less probable as sole driving force since both cell 
types encountered the same conditions. Assuming that the mature B cells were 
generated by the proposed rescue mechanism expressing SL independent µH chains in 
the preB cell stage (see above) it could be conceivable that these µH chains are part of 
a repertoire chanelling the cells into the MZB compartment. The predisposition to 
develop into MZB cells could be the result of the specificities of the SL independent 
µH chains, recognizing for e.g. common self- and foreign antigens. This would be in 
accordance with the enrichment for MZB cells found in transgenic mice expressing 
self-reactive heavy chains (Martin and Kearney, 2000).  
Interestingly, although there seem to be forces driving the B cells into the MZB 
compartment in λ5-/- and other lymphopenic mice, the absolute number of MZB cells 
is usually not increased. Also IL-7 transgenic mice, showing an enhanced generation 
of B cells, have normal numbers of MZB cells (Ceredig et al., 2003). This argues for a 
defined size of this compartment. It has been shown that the retention of MZB cells in 
the marginal zone is dependent on the presence of other cell types like the marginal 
zone macrophages (Karlsson et al., 2003). A direct interaction between the MZB cells 
and marginal zone macrophages was shown and its interruption led to relocalization 
of the MZB cells. Therefore it would be conceivable that the maintenance of a certain 
number of MZB cells is defined by the number of interacting cells, like e.g. marginal 
zone macrophages. The fact that BAFF transgenic mice nontheless have more MZB 
cells (Batten et al., 2000), could mean that BAFF not only acts on B cells but also on 
other cells, enlarging thereby the “compartment size” of MZB. Alternatively, BAFF 
could participate in the mechanisms establishing the “compartment size” (Lesley et 
al., 2004; Thien et al., 2004). 
MZB cells are considered as a first line of defense joining in with the B1 B cells 
against bacterial and some viral pathogens thereby bridging the time gap between the 
innate and the adaptive immune response. The enrichment of specificities to common 
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non-protein antigens (not easily altered by organisms) in the MZB would be in 
accordance with the current view of MZB cells. In B lymphopenic mice, like the λ5-/- 
mice, there is a tendency to maintain this first line of defense. The mechanisms by 
which this is achieved are not yet clear. It is not known if this is a result of enhanced 
antigenic selection or abundance of resources. In the case of SL deficient mice, 
inherent properties of the preBCR independent rescue mechanism could also be the 
reason. Finally, also a combination of the different mechanism could result in the 
formation of a fairly normal MZB and B1 compartment.  
The experimental data, shown here, demonstrate that the limited number of B cells 
generated in λ5 deficient mice are functional in terms of TI and TD immune 
responses including the secondary immune response. Detailed analysis shows that 
they are predominantly located in the B1 and MZB compartment. BrdU labeling 
kinetics reveal that the turnover of the splenic B cell populations, FOB as well as 
MZB, is reduced two- to threefold demonstrating that the decreased generation of B 
cells also influences the adult MZB compartment in λ5-/- mice. Interestingly, λ5-/- 
adult bone marrow cells seem to have a propensity to develop into MZB cells. Further 
experiments would have to be done analyzing for e.g. the µH repertoire in wild type 
and λ5-/- MZB cells. Furthermore, it would be informative to test the expressed µH 
chains of MZB cells, developed in λ5-/- mice, for SL independent expression to 
unravel the mechanisms behind the channeling of B cells into the “effector” branch of 
the B cell compartment in λ5 deficient mice. 
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5 Summary 
 
Antigen receptor variability is mostly generated by the V(D)J recombination 
mechanism. During V(D)J recombination hairpinned DNA ends are generated as 
intermediate reaction products, which have to be opened before religation can take 
place. One complex, which had been suggested to constitute the hairpin opening 
activity, was the Mre11/Rad50/Nbs1 (MRN) complex. This complex was known to be 
involved in DNA repair and hypothesized to participate in the non homologous end 
joining (NHEJ) pathway, the repair mechanism involved in V(D)J recombination. 
Additionally, it was shown that Mre11, as part of the ternary MRN complex, 
displayed hairpin opening activity in vitro, altogether making (Paull and Gellert, 
1999) it conceivable that the complex is involved in V(D)J recombination.  
To test whether or not the MRN complex, and accordingly Nbs1, is involved in 
hairpin opening at coding ends, we quantitatively and qualitatively analyzed V(D)J 
recombination with a cellular recombination assay in cells of healthy controls and 
cells of Nijmegen breakage syndrome (NBS) patients, the latter carrying a mutated 
Nbs1 gene. No obvious difference was detected, neither in recombination frequencies 
nor in the quality of signal joint or coding joint formation. Endogenous CDR3 regions 
of the Igκ and the Igλ chain loci of lymphocytes of NBS patients also showed no 
differences compared to healthy controls. These results led to the conclusion that 
Nbs1, and as a consequence the MRN complex, is not directly involved in the 
processing of DNA ends during V(D)J recombination. 
KRC, for kappa binding and RSS recognition component, was identified based on its 
ability to bind to the RSS (Wu et al., 1993). This RSS binding specificity was shown 
to be regulated by phosphorylation and to decrease upon RAG expression. Together 
with its mainly lymphoid expression pattern, it made it conceivable that KRC 
participates either in the V(D)J recombination mechanism itself or in the regulation of 
it. Additionally, KRC had been shown to be involved as a modulator in TNF-α 
signaling, suggesting an additional function for KRC in lymphocyte function and 
survival.  
To investigate the role of KRC in lymphocytes the KRC locus was targeted in order to 
analyze the effects of KRC deficiency on V(D)J recombination and lymphoid cells in 
general. Heterozygous mice were obtained but no homozygous mice were born due to 
very early embryonic lethality caused by the introduced mutation. Closer 
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characterization of the targeted locus revealed that the integration of the targeting 
construct into the locus had ocurred homologously only with one homology arm, 
whereas the other arm had integrated randomly. Additionally, a second integration 
into an intronic region of the KRC locus was detected. Whether the early embryonic 
lethality observed in our line of mice was due to KRC deficiency, based on a possible 
involvement of KRC in early zygotic/embryonic signaling, or rather due to the 
additional integration event, remains to be determined. 
During B cell development the IgH chain locus is the first locus where V(D)J 
recombination takes place. The resulting µH chain is subsequently tested for pairing 
with the surrogate light (SL) chain and for expression on the cell surface, as part of 
the preBCR. Deficiency in λ5, one component of the SL, partially blocks early B cell 
development at the preB-I to preB-II stage transition, resulting in B lymphopenia 
(Kitamura et al., 1992). The rate of generation of B cells and also the size of the B cell 
compartment itself apparently influence, amongst other factors, both the composition 
and the size of peripheral B cell compartments. B lymphopenic situations, like in the 
case of λ5-/- mice, seem to favour the development of B cell types, considered to be 
more innate, like marginal zone B cells (MZB). λ5 deficient mice had not been 
analyzed in this respect, so that we decided to characterize the mature B cell 
compartments in λ5 deficient mice. 
Analysis of the peritoneal B cell compartment of λ5-/- mice showed that conventional 
B2 B cells were hardly detectable and the B1b B cell population was reduced, 
whereas the B1a B cells were present in normal numbers. The splenic B cell 
compartment of λ5 deficient animals was diminished, mainly due to the reduction of 
follicular B (FOB) cells. In contrast, MZB cells were present in normal numbers in 
λ5-/- mice. BrdU labeling kinetics revealed a slower turnover of FOB as well as MZB 
cells in λ5 deficient animals, probably due to lowered influx of newly generated B 
cells. Functionally, λ5-/- mice were able to mount both primary and secondary thymus-
dependent as well as thymus-independent responses, albeit mostly at reduced levels. 
Additionally, we tested the competitive reconstitution ability of λ5-/- cells in mixed 
bone marrow chimeras between wild type and λ5-/- bone marrow cells. The results are 
preliminary, but suggest that λ5 deficient bone marrow can reconstitute to a limited 
extent, even in competition with wild type cells. Surprisingly, λ5-/- deficient cells were 
enriched in the MZB compartment, implicating that they have an intrinsic propensity 
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to develop into MZB cells. In summary, the data show that in λ5 deficient mice B 
cells preferentially develop into more innate-like B cell types. 
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6 Abbreviations 
 
aa   amino acid 
ATM  ataxia telangiectasia mutated 
BCR  B cell receptor 
BM  bone marrow 
BMP  bone morphogenetic protein 
BrdU  5-bromo-2'-deoxyuridine  
BSA   bovine serum albumine 
CJ  coding joint 
CD  cluster (complex) of differentiation 
CDR  complementarity determining region 
CSR  class switch recombination 
DMSO  dimethylsulfoxide 
DN  double negative 
DP  double positive 
dpc  days post coitus 
DSB  DNA double strand break 
DTT  dithiothreitol 
EDTA  ethylenediamine-tetraacetate 
ES cells embryonic stem cells 
FACS  fluorescence activated cell sorting 
FCS  fetal calf serum 
FITC  fluoresceinisothiocyanate 
FOB  follicular B cells 
FSC  forward scatter 
H chain heavy chain 
Ig  immunoglobulin 
i.p.  intraperitoneally 
i.v.  intravenously 
kb  kilo bases 
KRC  kappa B and RSS recognition component 
L chain light chain  
min  minutes 
MHC  major histocompatibility complex 
MLN  mesenteric lymph nodes 
MRN  Mre11/Rad50/Nbs1 complex 
MZB  marginal zone B cells 
MW  molecular weight 
NBS  Nijmegen breakage syndrome 
NIP  4-Hydroxy-3-iodo-5- nitrophenylacetyl 
NHEJ   non homologous end joining 
OD  optical density 
ON  over night 
pc  post coitus 
PCR  polymerase chain reaction 
PEC  peritoneal cells 
PI  propidium iodide 
preBCR pre-B cell receptor 
rpm  rounds per minute 
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RAG  recombination activating gene 
RSS  recombination signal sequence 
RT   room temperature 
RT-PCR reverse transcriptase-PCR 
SCID  severe combined immunodeficiency 
SDS  sodium dodecylsulfate 
sIgM  surface IgM 
SJ  signal joint 
SL  surrogate light chain 
SP  single positive 
SSC  side scatter 
TCR   T cell receptor 
TD   thymus dependent 
Tdt  terminal deoxynucleotidyl transferase 
TI   thymus independent 
UTR  untranslated region 
UV  ultra violett 
WT   wild type 
ZAS  zinc fingers/acidic motif/Ser/Thr-rich region domain 
ZnF  zinc finger 
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7 Materials and Methods 
 
7.1 General buffers and solutions 
 
DNA loading buffer, 6x   0,25% bromophenol blue 
      0,25% xylencyanol  
      1 mM EDTA  
      30% glycerol 
 
PBS      137 mM NaCl 
2.7 mM KCl 
8 mM Na2HPO4 
1.5 mM KH2PO4 
      pH 7.2 
 
20xSSC     3 M NaCl 
      300 mM sodium citrate  
      pH 7.0 
 
TAE      40 mM Tris-acetate pH 8.0  
      1 mM EDTA 
 
TE      10 mM Tris/HCl pH 8.0 
      1 mM EDTA 
 
5x PCR S buffer     50 mM Tris-HCL pH 8.8 
250 mM KCl 
7.5 mM MgCl2 
 
ELISA buffer      4% BSA 
      0,1% Tween 
       10 mM NaN3 
in PBS 
 
ELISA-substrate buffer   0.1 g MgCl2 x 6 H2O 
800 ml ddH2O 
      10 ml 1 M NaN3 
      100 ml diethanolamine 
      adjust to pH 9.8 with conc. HCl  
      add to 1 l with ddH2O 
 
FACS-buffer     2%FCS  
10 mM NaN3 in PBS 
 
ACK red blood cell lysis buffer  0.15 M NH4Cl 
1.0 mM KHCO3 
0.1 mM EDTA 
filter through a 0.2 µm filter 
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PBST      0.1% Tween 20 in PBS 
      
Proteinase K solution    10 mM Tris/HCl pH 8 
      5 mM EDTA pH 8 
      1 % SDS 
      300 mM sodium acetate pH 8 
      add fresh 200 µg/ml Proteinase K 
 
Mouse tail lysis buffer   50 mM Tris/Cl pH 8.0 
      5 mM EDTA 
      100 mM NaCl 
0,5% SDS 
Add freshly 20µl / 750µl buffer 10 
mg/ml proteinase K  
 
Southern blot hybridization solution  171 ml 1 M Na2HPO4 
      79 ml 1 M NaH2PO4 
175 ml 20% SDS 
1 ml 0.5 M EDTA pH 8.0 
Add to 500 ml 
Filter 0.45 µm 
Keep at RT, heat in case of precipitate 
 
Southern blot washing solution  54.72 ml 1 M Na2HPO4 
      25.28 ml 1 M NaH2PO4 
      100 ml 20 % SDS 
      4 ml 0.5 mM EDTA pH 8.0 
      Add to 2 l 
 
Blastocyst digestion buffer   50 mM KCl 
      10 mM Tris/Cl (8.0) 
2.5 mM MgCl2 
0.1 mg/ml gelatine 
0.45% NP40 
0.45% Tween 
 
7.2 Bacterial media and supplements 
 
LB      10 g tryptone 
      5 g yeast extract 
      10 g NaCl  
      dissolved in 1 l H2O 
autoclaved 
added 15 g agar for LB plates 
 
ampicillin     sodium salt in H2O 
stock 100 mg/ml 
used at 100µg/ml 
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kanamycin     stock 20 mg/ml in H2O 
      used at 50 µg/ml 
 
chlorampenicol    stock 30 mg/ml in ethanol, 
      use at 150 µg/ml 
 
tetracyclin     stock 5 mg/ml in ethanol, 
      used at 50 µg/ml 
 
7.3 Cell culture media and supplements 
 
Medium for MEF 
 
1000 ml DMEM (+Glutamax, high glucose) Gibco BRL 41966-029 
    50 ml FCS     Gibco BRL  
    12 ml Na-Pyruvate+MEM (100 mM) Gibco BRL 11360-039 
    20 µl 1-Thioglycerol   Sigma M-6145 
    12 ml Penicillin Streptomycin  Gibco BRL 15140-114 
      5 ml 200mM Glutamine   Gibco BRL 
filter sterilized (0,22 µm filter) 
 
Medium for ES cells 
 
1000 ml Knock-out DMEM    Gibco BRL 10829-018 
  120 ml FCS (ES Cell qualified)  Gibco BRL  
    12 ml Na-Pyruvate+MEM (100 mM) Gibco BRL 11360-039 
    20 µl 1-Thioglycerol   Sigma M-6145 
    12 ml Penicillin Streptomycin  Gibco BRL 15140-114 
   1 x 105 U/ml ESGROTM (LIF)  Gibco BRL 13275-011 
   10 ml 200mM Glutamine   Gibco BRL 
filter sterilized (0,22 µm filter) 
 
Gelatine solution for coating plates 
 
1,5 g gelatine (Type A from porcine skin) Sigma G-1890 
dissolved in 1000 ml PBS or 0,9% NaCl saline, autoclaved 
 
Trypsin solution  
 
10 ml Trypsin (10x) in 100 ml PBS (sterile) Gibco BRL 
 
G418 Stock-solution 
 
5 g G418 sulfate    Gibco BRL 11811-031 
in 37 ml  ES cell medium and 0.4 ml 10M NaOH, 300µg/ml active concentration  
 
Freezing medium 
 
90% FCS  
10% DMSO 
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7.4 Vectors 
 
vector Insert Constructor, 
Reference 
Application 
pCR4-TOPO (4 kb) none Invitrogen Cloning of PCR 
fragments with TA 
additions 
pDZ18 pBSL-flneo-DT4 
(6.6 kb) 
1.5 kb flox-neo Bsp120I-
XbaI fragment 
pGI2neo(m)+ into NotI-
XbaI linearized pBSL-DT4 
D. Zimmer, 
BII 
Backbone of the KRC 
targeting construct 
pDZ19 pBSL-flneo-
DT4tox (6.6 kb) 
1.5 kb flox-neo Bsp120I-
XbaI fragment into NotI-
XbaI linearized pBSL-
DT4tox 
D. Zimmer, 
BII 
Backbone of the KRC 
targeting construct, 
attenuated DTA cassette 
pDZ18-KRC-L/R (14.5 
kb) 
1 kb fragment of 
amplified KRC genomic 
DNA (primer 665/664) 
into the NotI site and the 
7kb KRC fragment of 
(primer 833/832) into 
the AscI site of pDZ18 
pBSL-flneo-DT4 .  
E. Harfst, 
this thesis 
KRC targeting construct 
pDZ19-KRC-L/R (14.5 
kb) 
1 kb fragment of 
amplified KRC genomic 
DNA (primer 665/664) 
into the NotI site and the 
7kb KRC fragment  
(primer 833/832)  into 
the AscI site of pDZ19 
pBSL-flneo-DT4 .  
E. Harfst, 
this thesis 
KRC targeting construct, 
attenuated DTA cassette 
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7.5 Primers 
 
Primer Sequence (5'-3') Application 
664 KRC 5' left  gcggccgcccggactagggatgacaggcccatgg Cloning of the 5' arm of the KRC targeting 
construct, + NotI site 
665 KRC right 3´ gcggccgctgcagtattgacatatatacttgcctg Cloning of the 5' arm of the KRC targeting 
construct, + NotI site, left arm southern probe 
689 + 856 int-neo  ggtatcgccgctcccgattcgc Internal neo primer used for targeting screening 
PCR 
859 pDZ18/19-L-3´ ccgagctcgaattcgagctctcccatatggtcg Internal targeting construct primer used for 
targeting screening PCR 
718 moKRCf  catggatcctgaccaaagcatcaagggcacc Inverted PCR for cloning of flanking genomic 
sequences, exon II 
719 moKRCr ggttggccagtgtgtgtggtgaccccaag Inverted PCR for cloning of flanking genomic 
sequences, exon II 
722 moKRCnestf ccccaaactccctgagtagcatctgaagtc Inverted PCR for cloning of flanking genomic 
sequences, exon II 
723 moKRCnestr  atggagctgctgcgatccagtggtgggaag Inverted PCR for cloning of flanking genomic 
sequences, exon II 
726 moKRC SOE f ctcttctccttgcaacagctcttgcctcag Inverted PCR for cloning of flanking genomic 
sequences, exon II 
727 moKRC SOE r  ctgaggcaagagctgttgcaaggagaagag Inverted PCR for cloning of flanking genomic 
sequences, exon II 
740 mKSf  acatatctccctcggccgcggcctcgcaca Inverted PCR for cloning of flanking genomic 
sequences, exon II 
741 mKSr  atcaaaggagtagctaccacggaaggtgtg Inverted PCR for cloning of flanking genomic 
sequences, exon II 
744 mKMf  cacaccttccgtggtagctactcctttgat Inverted PCR for cloning of flanking genomic 
sequences, exon II 
745 mKMr  tgtgcgaggccgcggccgagggagatatgt Inverted PCR for cloning of flanking genomic 
sequences, exon II 
786 KRC-exon3-5 ctttccaatctgaccatgagaacacc Cloning of the 3' targeting arm and inverted PCR 
787 krc-exon3-3 ggtggtagaaggtctccacacagg Cloning of the 3' targeting arm and inverted PCR 
788 krc-exon2-3 cctgcctcaggatgcggagctgtgg Cloning of the 3' targeting arm and inverted PCR 
789 krc-exon2-5  cttgtcttcagatgtatccgaccc Cloning of the 3' targeting arm and inverted PCR 
790 KRC-exon3-5'  gggtcaagatcttcgaaggaggg Cloning of the 3' targeting arm and inverted PCR, 
right arm southern probe-> left end 
791 KRC-5'introninside  catggacaccgaccagcccctctcc Cloning of the 3' targeting arm and inverted PCR 
792 KRC-5'intronoutside  cttgggtacagtggcttcccatgcc Cloning of the 3' targeting arm and inverted PCR 
793 KRC-3'intronoutside  gcagtgagctccccaatgacaaacc Cloning of the 3' targeting arm and inverted PCR 
794 KRC-3'introninside atgactatcatggcagggagcatgg Cloning of the 3' targeting arm and inverted PCR 
803 KRC-exon-3-3'  aagtacatctgaatccaggtgcccc Cloning of the 3' targeting arm and inverted PCR, 
right arm southern probe-> left end 
806 jfk43e05.g1  cccaggagcttcctctatgccagcc Cloning of the 3' targeting arm and inverted PCR, 
right arm southern probe-> middle 
807 KRC-3'intronoutside2  ttggaggagataccatgtgtggtgg Cloning of the 3' targeting arm and inverted PCR 
808 KRC-3'introninside2  ctactgctccagcaccatgcctgcc Cloning of the 3' targeting arm and inverted PCR 
824 G10P604282  ggccctaacactggagggtagg Cloning of the 3' targeting arm and inverted PCR 
825 jmf46f06  tagtgggtagcaccgagccc Cloning of the 3' targeting arm and inverted PCR 
826 G11P60253FH6  atcccctgcatcctaccctcc Cloning of the 3' targeting arm and inverted PCR, 
right arm southern probe-> middle 
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Primer Sequence (5'-3') Application 
827 ml2C-a1623h08.p1c3'  tgcagctgggaagcaatggcaaggg Cloning of the 3' targeting arm and inverted PCR 
828 G10P608000FF7-2  atgttgttaggagcgggtgtggcg Cloning of the 3' targeting arm and inverted PCR 
829 mleC-a1623h08.p1c  ttcccttcctacccagttccactcc Cloning of the 3' targeting arm and inverted PCR 
830 ml2C-a3348a11.q1c ttgcttcagggaagatgagcgggg Cloning of the 3' targeting arm and inverted PCR 
831 G10P627493RH7 tgcgttatgccgtggggtgcgagg Cloning of the 3' targeting arm and inverted PCR 
832 790-AscI krc ttggcgcgccgggtcaagatcttcgaaggaggg Primer used for cloning of the 3' arm of the KRC 
targeting construct, + AscI site 
833 830-AscI krc ttggcgcgccttgcttcagggaagatgagcgggg Primer used for cloning of the 3' arm of the KRC 
targeting construct, + AscI site 
853 pDZ18/19-KRC-1kb  gcgggatatcactagtgcgg Inverted PCR for cloning of flanking genomic 
sequences, vector specific 
854 pDZ-18/19-7kb gatatcaagcttatcgatacc Inverted PCR for cloning of flanking genomic 
sequences, vector specific 
855 1,1-KRC-left5'new -NotI ccgtgatttctcctctgaggctgc 5' upstream genomic primer used for targeting 
screening PCR, left arm southern probe 
857 1,1-KRC-left5'-2  cagaattcaagggcagaagagg 5' upstream genomic primer used for targeting 
screening PCR 
858 int-neo-2  ggcgaatgggctgaccgcttcc Internal targeting construct primer used for 
targeting screening PCR 
859 pDZ18/19-L-3´ ccgagctcgaattcgagctctcccatatggtcg Inverted PCR for cloning of flanking genomic 
sequences, vector specific 
860 KRC-1,1-5'-3  ccgtgatttctcctctgaggctgctattctcc Inverted PCR for cloning of flanking genomic 
sequences, vector specific 
861 KRC-1,1-5 -´5  caatacagaattcaagggcagaagagg Inverted PCR for cloning of flanking genomic 
sequences, vector specific 
862 KRC-1,1-5'-4 862 cccagcatccattgtggcatctctcc Inverted PCR for cloning of flanking genomic 
sequences, vector specific 
863 KRC-II-5'-3  gtggaggcatcggtgtagtatgagtgtg 5' upstream genomic primer used for targeting 
screening PCR 
864 KRC-II-5'-2  gggtgcggcatcctgtttgaatgtctctg 5' upstream genomic primer used for targeting 
screening PCR 
865 KRC-II-5'-1  ctgtggacagcctcagtaaatccttttcc 5' upstream genomic primer used for targeting 
screening PCR 
866 KRC-7kb-3´ ccctgaattccccttaaagagatagcc Inverted PCR for cloning of flanking genomic 
sequences, right targeting arm 
867 KRC-7kb-5´2 cggtgttccagaagtcgataccagctcg Inverted PCR for cloning of flanking genomic 
sequences, right targeting arm 
868 pDZ18191kb5 853 gccgcgggatatcactagtgcgg Inverted PCR for cloning of flanking genomic 
sequences, vector specific 
869 pDZ18/19asc5'  gaattcgatatcaagcttatcgatacc Inverted PCR for cloning of flanking genomic 
sequences, vector specific 
870 pDZ18/19-Asc-5'-3 tattgaatatgatcggaattcctcgagtctagg Inverted PCR for cloning of flanking genomic 
sequences, vector specific 
871 pDZ1819Asc5'-2  atatcaagcttatcgataccgtcgacc Inverted PCR for cloning of flanking genomic 
sequences, vector specific 
899 Krc-exon2-rev1  ggctggcgctttagcatcc Inverted PCR for cloning of flanking genomic 
sequences, exon II 
900 KRC-exon2-f1  gaagagccacctgcctttggcagcc Inverted PCR for cloning of flanking genomic 
sequences, exon II 
901 KRC-exon2-r2  agctggctggggtgtagcacagtagg Inverted PCR for cloning of flanking genomic 
sequences, exon II 
902 KRC-exon2-r3 catattccttcaaagcttctgagcc Inverted PCR for cloning of flanking genomic 
sequences, exon II 
903 KRC-exon2-f2  gcctgacacagagcctgagccg Inverted PCR for cloning of flanking genomic 
sequences, exon II 
910 neo-int2  ccctgatgctcttcgtccagatcatcc Neo primer used for screening and southern blot 
probe 
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Primer Sequence (5'-3') Application 
911 neo-int1  tcggctgctctgatgccgccgtgttcc Neo primer used for screening and southern blot 
probe 
937 KRC exon II  tcctgtgcttgtagaggttactcttgg Exonic KRC primer used for screening for 
homozygous mice/blastocysts 
958 KRC-5 -´gen.probe3 ggagtgcagttaaagctggctaagac Southern genomic probe 3' of left targeting arm 
959 KRC-5 -´gen.probe-5 gcatcctcagacacttcttacctctc Southern genomic probe 3' of left targeting arm 
961 pDZ18/19outward  ccgcactagtgatatcccgc Inverted PCR for cloning of flanking genomic 
sequences, vector specific 
962 KRC-gen.probe-R-3´ cggaggtctggaaagaggatagat Southern genomic probe 3' of right targeting 
arm 
963 KRC-gen.probe-R-5´ agctggtatcgacttctggaacac Southern genomic probe 3' of right targeting 
arm 
964 Neo-5´  ccattgaacaagatggattgc Southern neomycin probe 
965 Neo-3´  tcagaagaactcgtcaagaagg Southern neomycin probe 
968 665-rev  caggcaagtatatatgtcaatactgcagcggcc Inverted PCR for cloning of flanking genomic 
sequences, vector specific 
983 pDZ-1,1-3 -´nest  tgcagcggccgcctgcaggtcgacc Inverted PCR for cloning of flanking genomic 
sequences, vector specific 
984 pDZ-1,1-5 -´nest  ctagtccgggcggccgcactagtg Inverted PCR for cloning of flanking genomic 
sequences, vector specific 
985 pDZ18/19-3'Asc-out2  actcttcatcctcttcctcaatctcg Inverted PCR for cloning of flanking genomic 
sequences, vector specific 
986 pDZ18/19-3'Asc-out  ctattcctgtacatctgggcctacgg Inverted PCR for cloning of flanking genomic 
sequences, vector specific 
987 961+4  gcggccgcactagtgatatcccgc Inverted PCR for cloning of flanking genomic 
sequences, vector specific 
E-21 RT-vector-for cctcgagatccgaacaaacg Genomic real time PCR quantitation detecting 
vector sequences 
E-22 RT-KRC-WT-for cgagggagaaagcacagactct Genomic real time PCR quantitation detecting 
WT KRC targeted sequences 
E-23 RT-control locus -for tgctggatgggcagatcag Genomic real time PCR quantitation detecting 
vector WT exonic 5' of exon VIIsequences 
E-24 RT-vector-rev gatcggcaataaaaagacagaataaa Genomic real time PCR quantitation detecting 
vector sequences 
E-25 RT-KRC-WT-rev catctgtggagggacctgatg Genomic real time PCR quantitation detecting 
WT KRC targeted sequences 
E-26 RT-control locus -rev gcagaggagaaaccaggtaactg Genomic real time PCR quantitation detecting 
vector WT exonic 5' of exon VIIsequences 
E-30 KRC-L-5 -´2 agcatccattgtggcatctct Inverted PCR for cloning of flanking genomic 
sequences, KRC intron I 
E-31 KRC-L-5 -´1 caatacagaattcaagggcagaag Inverted PCR for cloning of flanking genomic 
sequences, KRC intron I 
E-32 2int-gen5´ gtggagaagaggactggctacata Inverted PCR for cloning of flanking genomic 
sequences, KRC intron I 
E-33 KRC-vector-L3´ gtctgaagaggagtttacgtccag Inverted PCR for cloning of flanking genomic 
sequences, vector specific 
E-34 RT-Rarm-f cacttcccgtggtgctgaa Genomic real time PCR quantitation detecting 5' 
targeting arm sequences 
E-35 RT-Rarm-r gtgggcaaggcagagacagt Genomic real time PCR quantitation detecting 5' 
targeting arm sequences 
E-36 KRC-L-3 -´gen ctgtgtgtgagcgaatgtgttt Inverted PCR for cloning of flanking genomic 
sequences, KRC exon II 
GABAR1-E7-f tgcgcctggaggactttaac Genomic real time PCR quantitation, GABA-
Receptor 1 control locus, gift of Samuel Barbieri 
GABAR1-E7-r ttcatggcccggtagatttg Genomic real time PCR quantitation, GABA-
Receptor 1 control locus, gift of Samuel Barbieri 
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7.6 Antibodies 
 
7.6.1 Antibodies for FACS Analysis 
 
Commercial antibodies were diluted 1:200 final dilution for FACS staining.  
 
Antigen      Clone 
 
α-mouse IL7-R (CD127)  (A7R34) PE   eBioscience 
α-mouse CD21 (CR2/CR1)  (7G6)  FITC   PharMingen  
α-mouse CD23 (FcεRII) (B3B4) FITC/PE  PharMingen  
α-mouse CD9   (KMC8) Biotin   PharMingen  
α-mouse CD1d (CD1.1) (1B1)  Biotin   PharMingen  
α-mouse CD5 (Ly.1)   (53-7.3) Biotin   PharMingen 
α-mouse CD4 (L3T4)  (RM4-5) APC   PharMingen  
α-mouse CD8α (Ly-2)  (53-6.7) PE   PharMingen  
α-mouse CD3ε   (142-2C11) APC   PharMingen  
α-mouse CD25 α-chain (7D4)  FITC   PharMingen  
     
Antibodies produced in the laboratory had been individually titrated beforehand.  
 
α- mouse IgM   (M41)    (Leptin, 1985) 
α- mouse CD19   (1d3) 
α- mouse IgD    (1.19) 
α- mouse c-kit (CD117) (ACK4)    (Ogawa et al., 1991) 
α- mouse 493 (C1qRp, AA4.1)     (Rolink et al., 1998) 
 
Secondary FACS reagents 
 
Streptavidin-PE-Cy7   Dil: 1:400  PharMingen 
Streptavidin-APC  Dil: 1:200  Becton Dickinson 
Streptavidin-PE   Dil: 1:1000  Southern Biotech 
 
7.6.2 Antibodies for ELISA 
       Dilution  
Goat α-mouse IgG   AP conjugate  1:1000 Southern Biotech 
Goat α-mouse IgM   AP conjugate  1:1000 Southern Biotech 
Goat α-mouse IgG1    AP conjugate  1:1000 Southern Biotech 
Goat α-mouse IgG2a    AP conjugate  1:1000 Southern Biotech 
Goat α-mouse IgG2b    AP conjugate  1:1000 Southern Biotech 
Goat α-mouse IgG3 (R40-82) AP conjugate  1:1000 PharMingen 
 
7.6.3 Antibodies for Histology  
     Dilution 
Biotinylated Peanut agglutinin  1:200 Vector Laboratories 
T24 (α-Thy1.1) FITC  1:50 produced in the laboratory 
Moma-1   bio  1:50 produced in the laboratory 
Ly5.1   bio or FITC 1:50 produced in the laboratory 
Ly5.2    bio or FITC 1:50 produced in the laboratory 
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M41 (α-IgM)  APC  1:50 produced in the laboratory 
Streptavidin RPE    1:200  Southern Biotech  
Neutralite Avidin-TXRD   1:200 Southern Biotech  
 
7.7 Molecular biology methods 
 
7.7.1 Agarose gel electrophoresis of DNA fragments 
 
DNA was separated for analytical or preparative purposes by gel electrophoresis using 
0.75% (w/v) agarose gels containing already 0.1 µg/ml ethidium bromide in 1 x TAE. 
6x sample buffer was added to each sample. Electrophoresis was performed at 3-5 
V/cm. 
 
7.7.2 Preparation of electro-competent E. coli  
 
1 l of LB medium was inoculated with 10 ml of fresh overnight culture of bacteria. 
Bacteria were grown at 37°C shaking to an OD600 of 0.7-0.9. The culture was then 
chilled on ice for half an hour and eventually centrifuged at 1500 g and 4°C for 15 
minutes. The pellet was then resuspended in 1 l of ice-cold 0.5 mM HEPES (pH 7.0) 
and again centrifuged at 1500 g and 4°C for 15 minutes. Cells were resuspended in 
500 ml ice-cold 0.5 mM HEPES (pH 7.0) and pelleted again by centrifugation. Next 
the bacteria were resuspended in 20 ml ice-cold 10% glycerol, again centrifuged and 
resuspended in 2 ml ice-cold 10% glycerol. Bacteria were fractioned in 400 µl 
aliquots , frozen on dry ice and stored at –70°C. 
 
7.7.3 Transformation of electro-competent E. coli 
 
Electro-competent E. coli were thawed on ice and 40-50 µl of bacterial suspension 
were tranferred into a prechilled 0.1 cm gap Gene Pulser cuvette (Bio-Rad). 1 µl DNA 
solution was added. The samples were pulsed with 1,6 kV, 25 µF and 200 Ω. After 
pulsing bacteria were immediately transferred into 1 ml of LB medium and incubated 
for around 1 hour at 37°C. Afterwards bacteria were spun down (7000 g, 1 min), 
resuspended in 70 µl of LB medium and plated onto selecting agar plates. After 
overnight growth at 37°C , colonies were expanded in LB with added corresponding 
antibiotic. On these mini-preps were performed and the isolated DNA was analyzed 
for the correct product by restriction digest.  
 
7.7.4 Preparation of plasmid DNA from E. coli  cultures 
 
Plasmid DNA was prepared with QIAGEN Maxi-prep and Mini-prep Kits according 
to the manufacturer´s protocols and dissolved in TE.  
 
7.7.5 Restriction enzyme digestion of DNA  
 
Restriction enyme digest was carried out in either 10 µl (for analytical purposes) or in 
20-50 µl volume (preparative digests) at conditions recommended by the 
manufacturer (NEB-Biolabs) with the appropiate enzyme buffer. Preparative digests 
were performed for at least 3 hours or ON, analytical digests for about 1 hour.  
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7.7.6 Purification of DNA from agarose gels  
 
Agarose gels were examined under UV light (366 nm) and the bands of interest 
excised as fast as possible to minimize exposure to UV light. Purification was then 
performed with the QIAquick Gel Extraction Kit (QIAGEN) according to the 
manufacturer´s protocol. 
 
7.7.7 Phosphatase treatment of DNA  
 
To prevent self-religation of vectors, after restriction enzyme digest, plasmids were 
treated with 1 U of calf intestine alkaline phosphatase for additional 30 minutes at 
37°C.  The alkaline phosphatase which removes 5´phosphates was then inactivated by 
heating the reaction mix to 75°C for 10 minutes. To remove the alkaline phosphatase 
gel electrophoresis was performed and the dephosphorylated vector was then 
gelpurified.  
 
7.7.8 Ligation of DNA fragments into vectors 
 
A) Ligations of restriction enzyme fragments with cohesive ends were performed 
at a molar ratio between vector and insert of 1:2-4 in a volume of 20 µl using 1 
µl of NEB T4 DNA ligase (400 U). The mix was either incubated 20 minutes 
at RT or ON at 16°C. 1 µl of the ligation reaction was then transformed into 
electro-competent bacteria.  
B) PCR fragments were directly cloned into the pCR-Vector or pCR-Blunt-vector 
(TA Cloning Kit or Zero Blunt PCR Cloning Kit ,Invitrogen) according to the 
manufacturer´s protocol.  
 
7.7.9 DNA Ethanol Precipitation 
 
Plasmid and genomic DNA was precipitated by adding 1/10 volume of 3 M sodium 
acetate (pH 4.8) and 2 volumes of 100% ethanol to the solution. The mixed DNA 
solution was then incubated for 20 minutes at –20°C followed by 15 minutes 
centrifugation (21 000 g, 4°C).  The pelleted DNA was then washed with ice-cold 
70% ethanol and air dried. DNA was dissolved either in TE or 10 mM Tris (pH 8.0).  
 
7.7.10 DNA phenol-choloroform Extraction 
 
To remove protein and other impurities of DNA solution a phenol-chloroform 
extraction was performed. For this 1 volume pure phenol (TE saturated) was added, 
the sample was shaken and spun for 10 minutes at RT and 21´000 g. The supernatant 
was transferred into a new tube and extracted with 1 volume of a 1:1 mixture of 
phenol and chloroform followed by a chloroform extraction. To precipitate the DNA 1 
volume isopropanol was added and 1/10 volume of 3 M sodium acetate. The mixture 
was let to precipitate at –20°C for 20 minutes. DNA was pelleted by a centrifugation 
for 20 minutes at 21´000g and 4°C. The pellet was air dried and redissolved in an 
appropiate volume of TE.  
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7.7.11 Polymerase chain reaction 
 
The PCR reactions were mixed on ice in 0.2 ml thermo PCR tubes. The set-up was the 
following: 
1-5 µl template DNA  
  6 µl 5x S PCR buffer 
  500 µM forward primer 
  500 µM reverse primer 
  200 µM each dNTP  
0.2 µl Taq-polymerase (0.25 U) (Roche Diagnostics) 
 
The PCR reaction was performed either in a T3 thermocycler (Biometra) or a 
Robocycler 96 (Stratagene) with the following standard protocol: 
 
94.5°C  2 min    initial denaturation  1 cycle 
94.5°C  30 sec 
x°C   30 sec    
72°C  60 sec / kb of expected product length 30-40 cycles 
72°C  5 min (or 1 1/2 x time of step 4)  1 cycle 
4°C   infinite 
 
Annealing temperature was calculated based on the primer sequence by adding up A 
and T as 2°C and counting G and C as 4°C.  The PCR product was analyzed after 
completed PCR reaction by gel electrophoresis and, if necessary, further processed i.e. 
purified and/or digested.  
 
7.7.12 Sequencing of plasmid DNA  
 
Sequencing of plasmid DNA was performed by capillary electrophoresis (ABI 
PRISM, Genetic Analyzer 310) using fluorescent terminator dideoxynucleotides 
supplied in a ready-to-use solution (Big Dye, Perkin-Elmer). The set-up was the 
following: 
 
up to 6 µl mini-prep DNA (1-2 µg) 
  1 µl primer (3.2 pmol/µl) 
  4 µl mix 
  add up to 20 µl with H2O  
 
The reaction was performed with the following standard program: 
 
96°C   30 sec 
50°C   15 sec    
60°C  4 min  25 cycles 
4°C   infinite 
 
The samples were ethanol precipitated by adding 80 µl of 75% ethanol, centrifuged at 
maximum speed for 20 minutes, washed once with 70% ice-cold ethanol, air dried and 
resuspended in 40 µl H2O. Sequencing was performed on the Genetic Analyzer 310 
(ABI PRISM) with a usual injection time of 3-4 seconds. Sequence analysis was 
performed using the ABI PRISM Autoassembler software (version 1.4.0). 
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7.7.13 Quantitative Real-Time PCR Assay 
 
7.7.13.1 PCR reaction setup for quantitative real-time PCR assay 
 
For reaction setup the Platinum® Quantitative PCR SuperMix-UDG universal PCR 
master mix (Invitrogen) was used. This master mix was a 2x concentrated premix of 
all necessary components, except primers, probe and template. To 12.5 µl master mix 
5 µl genomic DNA (6-12 ng total RNA), 300 mM forward and reverse primer and 
water were added to a final volume of 25 µl. Reactions were transferred to a 
MicroAmp® optical 96-well plate and covered with MicroAmp® optical caps (both 
from Perkin Elmer Applied Biosystems). The real-time PCR was performed in an 
ABIPRISM™ 7000 Sequence Detector (Perkin Elmer Applied Biosystems). The 
cycling conditions were 2 minutes 50°C, 10 minutes 95°C and 45 cycles of 
15 seconds 95°C denaturation, 1 minute 60°C combined annealing and primer 
extension. Data were evaluated with the SDS 1.6.3 software (Perkin Elmer Applied 
Biosystems). 
 
7.7.13.2 Primers and probes for real-time quantitative PCR 
 
Primers and probe sets for the genes of interest were designed with help of the Primer 
Express 1.0 software (Perkin Elmer Applied Biosystems) with the standard settings. 
Primers have an annealing temperature of 58 to 60°C. The amplicons size should be 
in the range of 50 to 200 bp to give consistent results. Primers were synthesized by 
QIAGEN (Germany). Following primers were used:  
E-34 RT-Rarm-f, E-35 RT-Rarm-r, GABAR1-E7-f, GABAR1-E7-r, E-21 RT-vector-
for, E-24 RT-vector-rev, E-22 RT-KRC-WT-for, RT-KRC-WT-rev, E-23 RT-control 
locus –for and E-25 E-26 RT-control locus–rev, see section primers.  
 
 
7.7.13.3 Interpretation of real-time PCR data 
 
The software (SDS 1.6.3) included in the ABIPRISM™ 7000 Sequence Detector 
(Perkin Elmer Applied Biosystems, Rotkreuz, Switzerland) analyses the emission data 
by first calculating the contribution of each component dye to the experimental 
spectrum. The reporter signal is then normalized with the signal of the passive 
reference dye, i.e. ROX (6-carboxy-X-rhodamine) which is included in the buffer but 
does not participate in the reaction. This normalization is necessary to correct for 
fluorescent fluctuations due to changes in concentration or volume. Normalization is 
accomplished by dividing the emission intensity of the reporter dye by the emission 
intensity of the passive reference to obtain a ratio defined as normalized reporter (Rn) 
for a given reaction tube. To reliably indicate the magnitude of the signal generated by 
the given set of PCR conditions, the SDS software calculates ∆Rn using the equation 
∆Rn= (Rn+) - (Rn-). Where Rn+ equals the ratio of reporter and passive reference at any 
given time during a reaction, and Rn- equals the mean of the reporter and passive 
reference ratio of cycles 3 to 15, resulting in a baseline. The threshold cycle value 
(CT) is the fractional cycle number at which the reporter fluorescence passes a fixed 
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threshold. This fluorescence threshold was set to the same value for all samples of the 
same gene. It was set manually in the exponential phase of the PCR amplification. 
 
7.7.13.4 Relative quantitation with the comparative method 
 
The gene of interest and an internal standard were assessed in separate tubes and 
relatively quantitated by the comparative method. Amplification eficiencies were used 
to normalize the assessed quantities (Liu and Saint, 2002). 
Three ∆Rn fluorescencethresholds were set manually in the exponential phase of the 
amplification reaction at the beginning, the middle and the end. The threshold cycle 
value (CT) is the fractional cycle number at which the reporter fluorescence passes the 
fixed ∆Rn threshold. Efficiency of amplification was then calculated with the 
following formula: 
 
The corrected value was then calculated with the following equation: 
 
             Ctsample    (1+ mean of efficiencies) Ctvaluecontrol 
               Ctcontrol    (1+ efficiency of sample) Ctvaluesample 
 
The ratio of the corrected values was used to relatively quantitate the amount of 
cDNA in the different samples.  
 
7.7.14 Preparation of genomic DNA of mouse tails  
 
A piece of 0.2-0.8 cm of mouse tail was cut and incubated ON at 56°C in mouse tail 
lysis buffer. After lysis 300 µl of saturated sodium chloride solution was added and 
the mixture was shaken for 5 minutes at RT followed by a 10 minutes centrifugation 
at 18´000 g and RT. 5 µl of the lysate supernatant were diluted in 150 µl H2O and 2 µl 
of this used as template for typing PCRs. 800 µl of the supernatant were transferred 
into a fresh tube and mixed with 500 µl isopropanol. The tubes were then centrifuged 
5 minutes at 18´000 g, the DNA pellet was washed with 70% ethanol (was left at –
20°C for some time with 70% ethanol), dried and resuspended for at least 1 hour at 
56°C in 70 µl TE. A 25 µl (10-15 µg DNA) aliquot was taken for a southern blot 
experiment.   
 
7.7.15 Extraction of ES cell genomic DNA  
 
After trypsinization ES cells of 1 24-well were transferred into 1 ml medium, washed 
once with PBS, resuspended in 400 µl proteinase K solution and incubated ON at 
55°C shaking in a thermoblock. The next day 200 µl phenol and 200 µl choloroform 
were added and the tubes were shaken and centrifuged 6 minutes at 21´000 g at RT. 
The supernatant was transferred into a new tube and 400 µl of chloroform were 
added. The tubes were shaken and again centrifuged at 21´000 g at RT. The 
supernatant was transferred into a fresh tube and the DNA was precipitated at –20°C 
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for 20 minutes after addition of 400 µl of isopropanol and 1 µl glycogen (20 mg/ml). 
Eventually tubes were spun for 20 minutes at maximum speed, washed once with ice-
cold 70% ethanol, air dried and resuspended in 50 µl TE for 1 hour at 55°C. Of this 
DNA solution 2 µl were  used as template for a 30 µl screening PCR reaction. ES 
cells were screened first in pools of 8-10 ES cell clones and of the positive pool(s) 
single clones were then analyzed.    
 
7.7.16 Southern blot analysis 
 
7.7.16.1 Digestion and gel electrophoresis of genomic DNA  
 
10-15 µg of genomic DNA were digested ON in a 100 µl digest with the 
corresponding enzyme buffer, 50 U restriction enyme and 100 µg/ml BSA. Digest 
efficiency was asessed the next day by gel electrophoresis of 3 µl of digest on an 
0.7% agarose gel. The digests were then ethanol precipitated and resuspended in 20 µl 
of TE. The complete genomic DNA digests were loaded into one lane of  a 0.7% 
agarose gel. Electrophoresis was performed ON with 1x TAE (without ethidium 
bromide) and at very low voltage (18-20 V). The gel was stained 20 minutes with 0.5 
µg/ml ethidium bromide and photographed with a ruler as reference.  
 
7.7.16.2 Alkaline Blotting 
 
The agarose gel was agitated in 0.25 N HCl for approximately 10 minutes. Then the 
DNA was denatured by soaking the gel in 0.4 N NaOH for 30 minutes. Meanwhile the 
nylon membrane (GeneScreen Plus, PerkinElmer Life Sciences) was cut to the exactly 
the same size as the gel and pre-wet in distilled water for a few seconds followed by 
an equilibration in 0.4 N NaOH for 10-15 minutes. Eventually a capillary blot was set 
up using 0.4 N NaOH as the transfer solution being careful to remove all bubbles 
wetween the different layers. Blotting was performed for 3 hours to ON. After transfer 
the membrane was washed in excess 2 x SSC for 1-2 minutes and the DNA was fixed 
by UV crosslinking onto the damp membrane (120 mJ, UV Stratalinker 2400, 
Stratagene).   
 
7.7.16.3 Labeling of a southern blot probe 
 
The 0.5-1,2 kb DNA probe which was mostly PCR amplified was labeled with the 
Random Primers DNA Labeling System (Invitrogen) according to the manufacturer´s 
manual with [α-32P]dATP as labeled nucleotide. Before hybridization the probe was 
separated from unincorporated nucleotides with MicroSpin S-300 or S-200 HR 
Columns (Pharmacia Biotech). 
 
7.7.16.4 Hybridization and washing of the blot 
 
The blot was prehybridized for 2 hours at 65°C with 30 ml of prewarmed 
hybridization solution. Immediately before hybridization the labeled probe was 
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denatured 5 minutes at 95°C, chilled on ice,  mixed with 20 ml prewarmed 
hybridization solution and poured onto the prehybridized membrane. Hybridization 
was performed ON at 65°C. Blots were washed with 100-200 ml of prewarmed 
washing solution 2 times for 20 minutes at 65°C. After washing the membrane twice 
in 2 x SSC it was wrapped in cling film and exposed either to phosphor imaging 
screens (3 hours to ON) and scanned with Phospho-Imager STORM (Molecular 
Dynamics) or exposed to BIOMAX MS films (Kodak) 1-2 days at –70°C using an 
intensifying screen.  
 
7.7.16.5 Stripping of blots 
 
The membrane was shaken in 0.2 M NaOH for 15 minutes at RT. Then the blot was 
neutralized 2 times 15 minutes in a 25 mM NaHPO4 pH 6.8 and 1 mM EDTA 
solution. Eventually the filter was newly hybridized or air dried. 
 
7.7.17 Typing of single blastocysts 
 
3.5 dpc blastocysts were taken, transferred individually into 30 µl of blastocyst 
digestion buffer and incubated for 1 hour at 55°C. Eventually the samples were heated 
10 minutes to 95°C. 2 µl of the supernatant were taken as template for a 30 µl nested 
PCR reaction.  
First and nested PCR followed the standard protocol with 40 cycles each, 1 minute 45 
seconds elongation time and 62°C annealing temperature. For the nested PCR 2 µl of 
the first PCR were used as template. The WT locus was detected by a PCR with the 
genomic primers 864 + 1008 for the first PCR and 865 + 937 for the second. The 
integration of the targeting construct was detected by a PCR with the genomic primer 
864 and the construct specific primer 856 in the first round and the genomic primer 
865 and construct primer 859.  
 
7.7.18 Identifying genomic integration sites by Inverse PCR  
 
The strategy was to obtain fragments of DNA including part of the integrated 
construct as well as flanking genomic sequence. Genomic DNA was digested with 
enzymes cutting in and outside of the integrated vector. The fragments were religated 
and eventually a PCR with construct specific primers was performed directed over the 
included unknown genomic region amplifying thereby the genomic flanking 
sequences. 
1 µg genomic DNA was digested separately with different restriction enzymes cutting 
inside the integrated construct (most possibly near to the construct ends). The digested 
DNA was purified using QIAquick PCR purification Kit (QIAGEN) and resuspended 
in 30 µl 10 mM Tris pH 8.0. Ligation of the DNA fragments was performed with the 
Rapid DNA Ligation Kit (Roche) according to the manufacturer´s manual using once 
66 ng of digested DNA in a 20 µl ligation or 766 ng DNA in a 60 µl volume. After 30 
minutes ligation at RT the ligase was heat inactivated at 65°C for 10 minutes. Then a 
Touch Down PCR (meaning starting with a high annealing temperature which is 
lowered in each cycle to enhanche specificity) was performed with 4 µl of the ligation 
reactions as template with the following program: 
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94°C   2 min    initial denaturation  1 cycle 
94°C   30 sec 
72°C   30 sec   ΔT -0.5°C 
72°C  5 min      20 cycles 
94°C   30 sec 
62°C   30 sec    
72°C  5 min      11 cycles 
72°C  10 min      1 cycle 
4°C   infinite 
 
Then the PCR products were purified with the QIAquick PCR purification Kit 
(QIAGEN) and a second Touch Down PCR was performed with nested primers with a 
similar program as for the first one only with 20 times steps 5-7. The PCR amplificats 
were analyzed on an agarose gel and were if distinct bands were discernable purified, 
cloned into the pCR-Vector with the TA Cloning Kit (Invitrogen), sequenced and the 
obtained sequences blasted against the mouse genome on the NCBI website. 
 
7.7.19 ELISA 
 
ELISAs were performed in 96-well flat-bottom Maxisorp immuno-plates (NUNC). 
Therefore the plates were coated with the corresponding antigen e.g. NIP-BSA at a 
concentration of 10 µg/ml in 50 µl PBS /well ON at 4°C. The plates were washed 2 
times with tap water with 0.05% Tween and then 100 µl of ELISA buffer were added 
to each well. A masterplate with ususally a 1:30 dilution in ELISA buffer of all sera to 
be analyzed was pipetted. 50 µl of these dilutions were then transferred into row A of 
the prepared antigen coated plates and serially diluted 1:3 till row H. The plates were 
incubated ON at 4°C and washed the next day 5 times with tap water (+Tween). Then 
50 µl of a 1:1000 dilution in ELISA buffer of the revealing antibody e.g. anti-IgM or 
anti IgG coupled to the alkaline phosphatase enzyme were given into each well. The 
plates were incubated 2 hours at 4°C and then washed again 5 times. Then 50 µl of 
the substrate solution (1 mg/ml of 4-Nitrophenylphosphate in ELISA substrate buffer) 
were added and the plates were incubated at RT for about 15 minutes. The reaction 
was stopped by adding 25 µl of 2.5 M NaOH and the plates were measured at 405 nm 
in a THERMOmax microplate reader (Molecular Devices). 
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7.8 Cellular techniques 
 
7.8.1 Lysis of red blood cells 
 
The cell suspension containing erythrocytes was centrifuged 5 minutes at 4°C and 
250 g and 4°C. Cells were resuspended in 1-2 ml of ACK buffer, let stand for 1-2 
minutes at RT. Lysis reaction was stopped by adding 10 ml FACS buffer. The cells 
were centrifuged again and then resuspended in medium. 
 
7.8.2 Surface staining of cells for FACS analysis  
 
For FACS staining normally cell suspensions of 20-10 x 106 cells/ml were prepared. 
The antibodies used were either directly labeled with fluorescent dyes like e.g. FITC 
or the antibodies were biotinylated and revealed by a second step with a fluorescently 
labeled streptavidin reagent. The appropiate dilutions for the antibodies had been 
titrated beforehand. Commercial antibodies were mostly used at a final dilution of 
1:200 in FACS buffer. 
For staining 50 µl of cell suspensions were mixed together with 150 µl of antibody 
dilution and stained in U-bottom 96-well plates. The cell suspensions were protected 
from light covered and incubated for at least 30 minutes on ice. Eventually 100 µl of 
FACS buffer were added to each well, the plates were spun for 5 minutes at 250 g and 
4°C, checked for cell pellets and the supernatant was flicked off. Cells were 
resuspended in the wells by vortexing the 96-well plate. Either the cells were then 
directly resuspended in 150 µl of FACS buffer and analyzed or staining procedure 
was repeated with the second step reagent for another 15 minutes on ice and the 
samples were then analyzed. If no PE–Cy7 was used as fluorescent dye for staining 
the cells they were resuspended in FACS buffer containing 10 µg/ml propidium 
iodide to discriminate between living and dead cells. Negative (no staining or only 
secondary reagent) and single stained compensation controls were always included. 
FACS analysis was carried out on a FACSCalibur (Becton Dickinson) and analyzed 
with the CellQuest Pro v4.0.1 software (Becton Dickinson). Cells were gated on the 
lymphoid FSC/SSC gate and, if included, on living cells excluding PI.  
 
7.8.3 Intracellular anti-BrdU staining 
 
Incorporated BrdU was detected by intracellular staining with the BrdU Flow Kit (BD 
Biosciences). For the intracellular staining at least 106 cells, better 2-3 x 106, were 
stained for the surface antigens as usual (including streptavidin combinations). All 
single stainings for compensation were performed. Basically the manufacturer´s 
protocol was followed.  
Surface stained cell pellets in tubes (no propidium iodide added) were centrifuged and 
resuspended in 100 µl Cytofix/Cytoperm and incubated for 20 minutes on ice. 1 ml of 
Permwash buffer was added and the cells were spun down, resuspended in 100 µl 
Cytoperm Plus and incubated 10 minutes on ice. Again 1 ml of Permwash was added, 
the cells were centrifuged, resuspended in 100 µl in the kit provided DNAse solution 
(alternatively DNAse I 2000 U/ml in PBS) and incubated 1 hour at 37°C. After this 1 
ml Permwash was added, cells were centrifuged, resuspended in 50 µl 1:100 dilution 
of the anti-BrdU antibody and incubated for 20 minutes at RT. Cells were then again 
washed with 1 ml Permwash, centrifuged, resuspended and analyzed on a 
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FACSCalibur (Becton Dickinson) with the CellQuest Pro v4.0.1 software (Becton 
Dickinson). 
 
7.8.4 Staining of sections for fluorescence microscopy 
 
The 5 µm organ sections were fixed 10 minutes in aceton and then stored at –20°C. 
Before staining the slides were allowed to thaw for 10 min at RT. Then a hydrophobic 
ring was drawn around the sections with a Dako Pen (DAKO) to minimize the need of 
antibody solution. For staining the sections were covered with antibody solution and 
incubated for 30 minutes at RT in the dark. Antibodies were used at a 1:50 dilution in 
FACS buffer, only biotinylated peanut agglutinin was diluted 1:200. After staining 
with the first antibody, slides were shortly rinsed in PBS and then washed by shaking 
another 15 minutes in PBS. For the second step sections were covered with Neutralite 
Avidin-TXRD (1:200) for 15 minutes at RT. Slides were then washed as described 
above, 1-2 drops of a 1:1 mixture of PBS and glycerin were given onto the slide 
which was then covered with a 24 x 45 mm cover glass (Medite).  
 
7.9 Mouse work  
 
7.9.1 Thymus dependent and independent Immuninzation 
 
5 week old λ5T/λ5T and 11 week old C57BL/6 mice were injected either s.c. with 
50 µg NIP-Ovalbumin with Freund’s complete adjuvant mixed 1:1 (TD) or i.v. with 
100 µg NIP-Ficoll in PBS (TI). For the secondary TD immune response mice received 
a second NIP-Ovalbumin injection after 4 month. Sera were obtained from tail 
bleeding and kept at –20°C until they were used. Total and hapten-specific Ig levels 
were determined by ELISA. 
 
7.9.2 BrdU labeling 
 
Mice received an initial intraperitoneal injection of 1mg BrdU dissolved in PBS and 
were thereafter fed with drinking water containing 1 mg/ml BrdU for different periods 
of time. The BrdU-containing drinking water was light protected and was changed 
every 4 days. Cells were then prepared from differnt lymphoid organs and were 
analyzed with the BrdU Flow Kit (BD Biosciences) as described in the section 
„Intracellular anti-BrdU staining“. 
 
7.9.3 Mixed bone marrow chimeras 
 
Donor bone marrow cells were harvested from 5 Ly5.2+ λ5T/λ5T and 5 Ly5.1+ 
C57BL/6 mice. Cells were spun 10 minutes at 10'000 rpm and red blood cell lysis was 
performed. Cells were resuspended in 3 ml PBS with 2% FCS (without sodium azide) 
and stained with α-CD3ε-PE (1:200) for 30 minutes. Eventually cells were washed 
with PBS/2% FCS, shortly spun (only till 600 rpm) and then filtered through a silk 
mesh. CD3ε- cells were conservatively sorted on a FACSAria (Becton Dickinson). 
Subsequently  cells were resuspended in 1 ml serum free DMEM, counted and diluted 
to a concentration of 2x106/ml. Four hours after completion of sublethal irradiation 
(450 rad) the male C57BL/6 Rag2-/- recipient mice were injected through the tail vein 
with 1x106 sorted donor bone marrow cells either only Ly5.2+ λ5T/λ5T or Ly5.1+ 
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C57BL/6 cells or a 1:1 mixture of both types. Approximately 4 weeks later different 
organs of the mice were analyzed for lymphoid engraftment and chimerism by flow 
cytometric analysis. 
 
7.10 Cell culture methods 
 
7.10.1 Determination of cell numbers 
 
A 10 µl aliquot of a cell suspension was diluted with 90 µl trypan blue solution 
(0.4% w/v) and cells were counted with a Neubauer counting chamber (0.1 mm 
depth). The number of living cells (excluding the dye) in 16 small squares multiplied 
with  by 104 gave the cell density of cells/ml. 
 
7.10.2 Freezing and thawing of cells 
 
Logarithmicly growing cells were frozen by pelleting them by centrifugation with 250 
g at 4°C and resuspending them in freezing medium. Then they were transferred into 
Cryotubes and placed ON at –70°C. For long-term storage they were transferred into 
the liquid nitrogen tank. 
Frozen cells were quickly thawn in a 37°C waterbath, immediately diluted 1:10 in the 
appropiate medium, centrifuged at 250 g and the cell pellet was then resuspended in 
fresh medium and cultured with the appropiate conditions.  
 
7.10.3 ES cell culture, transfection and selection 
 
 Gelatinizing of plates 
 
Tissue culture dishes (∅10 cm) were gelatinized by incubating them with 8 ml 0,15% 
gelatine-saline solution for around 15 minutes at RT. 
 
 MEF culture 
 
1 vial mouse embryonic fibroblasts (MEF or feeder cells) was thawed in a 37°C 
waterbath and resuspended in 60 ml  MEF medium. The gelatine solution of the plates 
was aspirated and 10 ml of MEF suspension was plated on each gelatinized plate. 
Feeder cells were incubated for around 3 days at 37°C and 10%CO2. 
 
 Trypsinization and replating of MEF   
 
Medium was aspirated of the feeder cells and the plates were rinsed once with PBS 
followed by a trypsinization of 5 minutes with 2 ml 1x trypsin solution. Trypsinzation 
was stopped by adding 8 ml of medium and the cells were harvested by pipetting the 
medium 6 to 7 times over the plate. Cells were collected, diluted according to the 
passage and plated in 10 ml medium on new gelatinized plates. For the second 
passage MEF were expanded from 6 to 26 plates and for the third passage cells could 
further be expanded 3 times. After 3 passages feeder cells were not split anymore but 
could be replated on different tissue culture dishes. 
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 Freezing of MEF 
 
MEF of 4 plates were harvested by trypsinization and frozen into 1 freezing vial with 
1 ml freezing medium. The vials were first transferred to –70°C ON and stored for 
longterm in the liquid nitrogen tank.  
 
 Culture of ES cells 
 
1-2 MEF plates were irradiated for 45 with 94 rad/min. 1 ES cell vial was thawed in a 
37°C waterbath and resuspended in 10 ml ES cell medium, spun down (1200 rpm, 5 
minutes) and resuspended in 10-20 ml fresh ES cell medium. The medium of the 
feeder cell plates was removed and ES cells were plated on 1-2 irradiated feeder cell 
plates. Cells were incubated at 37°C and 10% CO2 changing medium every day.  
 
 Expansion of ES cells 
 
Plates were washed once with PBS and trypsinized with 2 ml 1x trypsin solution for 
up to 5 minutes. 8 ml of ES cell medium was added, cells were harvested and 
resuspended. The cell suspension was transferred into a 15 ml tube and allowed to 
settle for 10-15 minutes. The upper 8 ml of the ES cell suspension were used for 
further expansion. 1 ml of the ES cell suspension was plated on 1 irradiated feeder 
cell plate with fresh ES cell medium.  
 
 Freezing of ES cells 
 
ES cells were harvested (as described above), the upper 8ml of cell suspension was 
centrifuged for 8 minutes at 1200 rpm and cells were resuspended in freezing medium 
(2-4 vials per plate). The tubes were transferred overnight to –70°C and for long-term 
storage into the liquid nitogen tank.  
 
 Transfection and selection of ES cells  
 
ES cells were harvested from 5-6 plates (as described above), the upper cell 
suspension was spun and resuspended in 20- 30 ml serum-free medium. Cells were 
counted and split into 1-2 x 107 cell fractions and again spun down. The fractions 
were then resuspended in 800 µl serum–free medium with 40 µg of linearized vector 
DNA (ON linearized vector, phenol chloroform extracted, ethanol-acetate 
precipitated, washed with 100% ethanol, resuspended in 50 µl  sterile TE and filter 
sterilized through a mini-0.2µm filter). The cell suspensions were then transferred into 
a 0.4 cm gap cuvette. Cells were pulsed with 0.22 kV and 960 µF. As selection 
control served a pulsed sample without DNA. Cells were directly resuspended after 
the pulse in ES medium and plate selection control sample on to 2 feeder plates and 
transfected cell sample on 4 plates of irradiated feeder cells.  
One day after transfection selection was started with 300 µg/ml G418. Medium was 
changed every day. 8-10 days after transfection, individual ES cell colonies were 
distinguishable which were then eventually picked.  
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 Picking ES cell colonies 
 
Medium on the ES cell plates was exchanged for PBS and the colonies were picked 
with a gilson pipette set on a volume of 50 µl. The aspirated colonies were transferred 
individually into 50 µl 1xtrypsin/EDTA solution in a 96-well plate and resuspended 
by pipetting. The cells suspension was halved and each part was plated onto an 
irradiated 96-well feeder plates with 150µl of ES cell medium with 300 µg/ml G418.  
 
 Expansion of ES cell colonies 
 
ES cells were always plated onto new feeder plates before the colonies touched each 
other or the colonies were growing to big. Wells were rinsed once with PBS and then 
trypsinized with a small volume of 1xtrypsin/EDTA solution (for e.g. 50 µl for a 96–
well) for around 10 minutes at 37°C. After resuspension with a pipette, the cell 
suspension was either transferred into a new well with irradiated feeder cells, frozen 
with at least 10 x volume of freezing medium or washed once with PBS and processed 
further for extraction of DNA.  
 
 
7.11 Computational methods 
 
7.11.1 In silico genome walking 
 
To obtain the unknown downstream intronic sequence of exon III of the KRC gene we 
took advantage of the ongoing sequencing project of the mouse genome. Different 
organizations like the Sanger Institute provided an open accessible archive of not yet 
assembled DNA sequencing reads coming from the whole genome shotgun projects. 
So the known sequence of exon III was used as a starting point to search it against the 
Ensembl trace repository (http://trace.ensembl.org/) with the SSAHA program 
(Sequence Search and Alignment by Hashing Algorithm). The retrieved matching 
sequences were then assembled using the Lasergene (DNASTAR) program resulting 
in a larger contiguous consensus sequence also referred to as contig. Eventually the 
most 3’ located sequences were again searched against the Ensembl trace repository, 
integrated into the contig and the latter that way extended. This was repeated until no 
matching sequences could be found anymore. In this case one took advantage of the 
fact that part of the sequence traces were marked as corresponding to the same 
genomic fragment (normally 2–4 kb) just representing the two different ends. 
Therefore one took sequence pairs with one sequence lying in the already assembled 
contig and took the other corresponding one as starting point for a new contig. 
Primers were then designed based on the gained uncontiguos sequence information 
with which the accuracy of the assembled sequences could be verified.  
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